Skip to main content Accessibility help
×
Hostname: page-component-68c7f8b79f-r8tb2 Total loading time: 0 Render date: 2025-12-19T10:30:43.419Z Has data issue: false hasContentIssue false

Section 1 - Infectious Conditions

Published online by Cambridge University Press:  15 June 2018

Edited by
Louis Caplan  and
José Biller
Louis Caplan
Affiliation:
Beth Israel-Deaconess Medical Center, Boston
José Biller
Affiliation:
Loyola University Stritch School of Medicine, Chicago
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type
Chapter
Information
Uncommon Causes of Stroke , pp. 1 - 76
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

References

Aho, K., Sievers, K. and Salo, O. P. 1969. Late complications of syphilis: A comparative epidemiological and serological study of cardiovascular syphilis and various forms of neurosyphilis. Acta Derm Venereol, 49, 336–42.10.2340/0001555549336342CrossRefGoogle ScholarPubMed
Aldrich, M. S., Burke, J. M., and Gulati, S. M. 1983. Angiographic findings in a young man with recurrent stroke and positive fluorescent treponemal antibody (FTA). Stroke, 14, 1001–4.CrossRefGoogle Scholar
Alpers, B. J. 1954. Clinical Neurology, 3rd edn. Philadelphia: FA Davis.Google Scholar
Bates, B., Choi, J. Y., Duncan, P. W., et al. 2005. Veterans Affairs/Department of Defense Clinical Practice Guideline for the Management of Adult Stroke Rehabilitation Care: Executive summary. Stroke, 36, 2049–56.10.1161/01.STR.0000180432.73724.ADCrossRefGoogle ScholarPubMed
Bordon, J., Martinez-Vazquez, C., Alvarez, M., et al. 1995. Neurosyphilis in HIV-infected patients. Eur J Clin Microbiol Infect Dis, 14, 864–9.CrossRefGoogle ScholarPubMed
Brightbill, T. C., Ihmeidan, I. H., Post, M. J., Berger, J. R., and Katz, D. A. 1995. Neurosyphilis in HIV-positive and HIV-negative patients: Neuroimaging findings. Am J Neuroradiol, 16, 703–11.Google ScholarPubMed
Buchacz, K., Patel, P., Taylor, M., et al. 2004. Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS, 18, 2075–9.10.1097/00002030-200410210-00012CrossRefGoogle ScholarPubMed
Burke, J. M. and Schaberg, D. R. 1985. Neurosyphilis in the antibiotic era. Neurology, 35, 1368–71.CrossRefGoogle ScholarPubMed
Centers for Disease Control and Prevention (CDC). 2002. Sexually Transmitted Diseases Treatment Guidelines 2002. Morbidity and Mortality Weekly Report, vol. 51, RR-6.Google Scholar
Centers for Disease Control and Prevention (CDC). 2015. Sexually Transmitted Diseases Treatment Guidelines Syphilis, 2015. Morbidity and Mortality Weekly Report, vol. 64, No. 3.Google Scholar
Clark, E. G. and Danbolt, N. 1955. The Oslo study of the natural history of untreated syphilis; an epidemiologic investigation based on a restudy of the Boeck–Bruusgaard material; a review and appraisal. J Chronic Dis, 2, 311–44.Google ScholarPubMed
Cordato, D. J., Djekic, S., Sanjeev, R., et al. 2013. Prevalence of positive syphilis serology and meningovascular neurosyphilis in patients admitted with stroke and TIA from a culturally diverse population. J Clin Neurosci, 20, 943–7.10.1016/j.jocn.2012.08.011CrossRefGoogle ScholarPubMed
Danielsen, A. G., Weismann, K., Jorgensen, B. B., Heidenheim, M., and Fugleholm, A. M. 2004. Incidence, clinical presentation and treatment of neurosyphilis in Denmark 1980–1997. Acta Derm Venereol, 84, 459–62.10.1080/00015550410017308CrossRefGoogle ScholarPubMed
Davis, L. and Schmitt, J. 1989. Clinical significance of cerebrospinal fluid tests for neurosyphilis. Ann Neurol, 25, 50–5.CrossRefGoogle ScholarPubMed
Davis, L. and Sperry, S. 1978. Bell’s palsy and secondary syphilis: CSF spirochetes detected by immunofluorescence. Ann Neurol, 4, 378–80.10.1002/ana.410040416CrossRefGoogle ScholarPubMed
Duncan, P. W., Zorowitz, R., Bates, B., et al. 2005. Management of adult stroke rehabilitation care: A clinical practice guideline. Stroke, 36, e100–43.CrossRefGoogle Scholar
Farhi, D. and Dupin, N. 2010. Origins of syphilis and management of the immunocompetent patient: Facts and controversies. Clin Derm, 28, 533–8.Google ScholarPubMed
Fisher, M. and Poser, C. M. 1977. Syphilitic meningomyelitis: A case report. Arch Neurol, 34, 785.10.1001/archneur.1977.00500240073015CrossRefGoogle ScholarPubMed
Flint, A. C., Liberato, B. B., Anziska, Y., Schantz-Dunn, J., and Wright, C. B. 2005. Meningovascular syphilis as a cause of basilar artery stenosis. Neurology, 64, 391–2.10.1212/01.WNL.0000149758.57386.B8CrossRefGoogle ScholarPubMed
Funnye, A. S. and Akhtar, A. J. 2003. Syphilis and human immunodeficiency virus co-infection. J Natl Med Assoc, 95, 363–82.Google ScholarPubMed
Gaa, J., Weidauer, S., Sitzer, M., Lanfermann, H., and Zanella, F. E. 2004. Cerebral vasculitis due to Treponema pallidum infection: MRI and MRA findings. Eur Radiol, 14, 746–7.10.1007/s00330-003-2015-4CrossRefGoogle ScholarPubMed
Gallego, J., Soriano, G., Zubieta, J. L., Delgado, G., and Villanueva, J. A. 1994. Magnetic resonance angiography in meningovascular syphilis. Neuroradiology, 36, 208–9.CrossRefGoogle ScholarPubMed
Gjestland, T. 1955. The Oslo study of untreated syphilis: An epidemiologic investigation of the natural course of syphilis infection based upon restudy of the Boeck–Bruusgaard material. Acta Derm Venereol, 35, 3–368, Annex I–LVI.Google ScholarPubMed
Golden, M. R., Marra, C. M., and Holmes, K. K. 2003. Update on syphilis: Resurgence of an old problem. JAMA, 290, 1510–4.10.1001/jama.290.11.1510CrossRefGoogle ScholarPubMed
Good, C. D., and Jager, H. R. 2000. Contrast enhancement of the cerebrospinal fluid on MRI in two cases of spirochaetal meningitis. Neuroradiology, 42, 448–50.CrossRefGoogle ScholarPubMed
Gray, F. and Alonso, J. M. 2002. Bacterial infections of the central nervous system. In Greenfield’s Neuropathology, 7th edn., Graham, D. I. and Lantos, P. L., eds. London: Arnold, pp. II:178–II:184.Google Scholar
Harrigan, E. P., McLaughlin, T. J., and Feldman, R. G. 1984. Transverse myelitis due to meningovascular syphilis. Arch Neurol, 41, 337–8.10.1001/archneur.1984.04050150119030CrossRefGoogle ScholarPubMed
Holland, B. A., Perrett, L. V., and Mills, C. M. 1986. Meningovascular syphilis: CT and MRI findings. Radiology, 158, 439–42.10.1148/radiology.158.2.3941870CrossRefGoogle Scholar
Hook, E. W. III, and Peeling, R. W. 2004. Syphilis control: A continuing challenge. N Engl J Med, 351, 122–4.CrossRefGoogle ScholarPubMed
Hooshmand, H., Escobar, M. R., and Kopf, S. W. 1972. Neurosyphilis. A study of 241 patients. JAMA, 219, 726–9.CrossRefGoogle ScholarPubMed
Hotson, J. R. 1981. Modern neurosyphilis: A partially treated chronic meningitis. West J Med, 135, 191–200.Google ScholarPubMed
Jay, C. A. 2006. Treatment of neurosyphilis. Curr Treat Options Neurol, 8, 185–92.10.1007/s11940-006-0009-7CrossRefGoogle ScholarPubMed
Jenier, M., Hegyi, V., Dupin, N., et al. 2014. 2014 European guideline on the management of syphilis. J Eur Acad Dermatol Venereol, 28, 1581–93.CrossRefGoogle Scholar
Johns, D. R., Tierney, M., and Parker, S. W. 1987. Pure motor hemiplegia due to meningovascular neurosyphilis. Arch Neurol, 44, 1062–5.10.1001/archneur.1987.00520220060018CrossRefGoogle ScholarPubMed
Kelley, R. E., Bell, L., Kelley, S. E., and Lee, S. C. 1989. Syphilis detection in cerebrovascular disease. Stroke, 20, 230–4.10.1161/01.STR.20.2.230CrossRefGoogle ScholarPubMed
Kelley, R. E., Minagar, A., Kelley, B. J., and Brunson, R. 2003. Transcranial Doppler monitoring of response to therapy for meningovascular syphilis. J Neuroimaging, 13, 85–7.10.1111/j.1552-6569.2003.tb00163.xCrossRefGoogle ScholarPubMed
Kierland, R. R., O’Leary, P. A., and Vandoren, E. 1942. Symptomatic neurosyphilis. J Vener Dis Inf, 22, 360–77.Google Scholar
LaFond, R. E, Lukehart, S. A. 2006. Biological basis for syphilis. Clin Microbiol Rev, 19, 29–49.10.1128/CMR.19.1.29-49.2006CrossRefGoogle ScholarPubMed
Landi, G., Villani, F., and Anzalone, N. 1990. Variable angiographic findings in patients with stroke and neurosyphilis. Stroke, 21, 333–8.CrossRefGoogle ScholarPubMed
Liu, L. L., Zheng, W. H., Tong, M. L., et al. 2012. Ischemic stroke as a primary symptom of neurosyphilis among HIV-negative emergency patients. J Neurol Sci, 317, 35–9.CrossRefGoogle ScholarPubMed
Lowenstein, D. H., Mills, C., and Simon, R. P. 1987. Acute syphilitic transverse myelitis: Unusual presentation of meningovascular syphilis. Genitourin Med, 63, 333–8.Google ScholarPubMed
Lukehart, S. A., Hook, E. W. III, Baker-Zander, S. A., et al. 1988. Invasion of the central nervous system by Treponema pallidum: Implications for diagnosis and treatment. Ann Intern Med, 109, 855–62.10.7326/0003-4819-109-11-855CrossRefGoogle ScholarPubMed
Lukehart, S. A., Godornes, C., Molini, B. J., et al. 2004. Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med, 351, 154–8.10.1056/NEJMoa040216CrossRefGoogle ScholarPubMed
Marra, C. M. 2004. Neurosyphilis. In Infections of the Central Nervous System, 3rd edn. Philadelphia: Lippincott, Williams & Wilkins, pp. 649–57.Google Scholar
Marra, C. M. 2015. Neurosyphilis. Continuum (Minneap Minn), 21, 1714–28.Google ScholarPubMed
Marra, C. M., Maxwell, C. L., Smith, S. L., et al. 2004a. Cerebrospinal fluid abnormalities in patients with syphilis: Association with clinical and laboratory features. J Infect Dis, 189, 369–76.CrossRefGoogle ScholarPubMed
Marra, C. M., Maxwell, C. L., Tantalo, L., et al. 2004b. Normalization of cerebrospinal fluid abnormalities after neurosyphilis therapy: Does HIV status matter? Clin Infect Dis, 38, 1001–6.CrossRefGoogle ScholarPubMed
Merritt, H. H., Adams, R. D., and Solomon, H. C. 1946. Neurosyphilis. New York: Oxford University Press, pp. 83–174.Google Scholar
Merritt, H. H. and Moore, M. 1935. Acute syphilitic meningitis. Medicine, 14, 119–83.10.1097/00005792-193502000-00003CrossRefGoogle Scholar
Moore, J. 1941. The Modern Treatment of Syphilis, 2nd edn., Springfield: CC Thomas.Google Scholar
Nabatame, H., Nakamura, K., Matuda, M., et al. 1992. MRI of syphilitic myelitis. Neuroradiology, 34, 105–6.10.1007/BF00588152CrossRefGoogle ScholarPubMed
Noordhoek, G. T., Engelkens, H. J., Judanarso, J., et al. 1991. Yaws in West Sumatra, Indonesia: Clinical manifestations, serological findings and characterization of new Treponema isolates by DNA probes. Eur J Clin Microbiol Infect Dis, 10, 12–9.10.1007/BF01967091CrossRefGoogle ScholarPubMed
Nordenbo, A. M., and Sorensen, P. S. 1981. The incidence and clinical presentation of neurosyphilis in Greater Copenhagen, 1974 through 1978. Acta Neurol Scand, 63, 237–46.Google ScholarPubMed
Peng, F., Hu, X., Zhong, X., et al. 2008. CT and MR findings in HIV-negative neurosyphilis. Eur J Radiol, 66, 1–6.CrossRefGoogle Scholar
Perdrup, A., Jorgensen, B. B., and Pedersen, N. S. 1981. The profile of neurosyphilis in Denmark. A clinical and serological study of all patients in Denmark with neurosyphilis disclosed in the years 1971–1979 incl. by Wassermann reaction (CWRM) in the cerebrospinal fluid. Acta Derm Venereol Suppl (Stockh), 96, 1–14.Google Scholar
Peterman, T., Heffelfinger, J., Swint, E., and Groseclose, S. 2005. The changing epidemiology of syphilis. Sex Transm Dis, 32, S4–S10.10.1097/01.olq.0000180455.79024.e9CrossRefGoogle ScholarPubMed
Peters, K. M., Adam, G., Biedermann, M., Zilkens, K. W., and Gunther, R. 1993. Osteomyelitis today: Diagnostic imaging and therapy. Zentralbl Chir, 118, 637–45.Google ScholarPubMed
San Francisco Department of Public Health. 2005. San Francisco Sexually Transmitted Disease Annual Summary, 2004.Google Scholar
Shockman, S., Buescher, L. S., Stone, S. P. 2014. Syphilis in the United States. Clin Derm, 32, 213–8.10.1016/j.clindermatol.2013.08.005CrossRefGoogle ScholarPubMed
Silber, M. H. 1989. Syphilitic myelopathy. Genitourin Med, 65, 338–41.Google ScholarPubMed
Simon, R. P. 1985. Neurosyphilis. Arch Neurol, 42, 606–13.10.1001/archneur.1985.04060060112021CrossRefGoogle ScholarPubMed
Timmermans, M. and Carr, J. 2004. Neurosyphilis in the modern era. J Neurol Neurosurg Psychiatry, 75, 1727–30.10.1136/jnnp.2004.031922CrossRefGoogle ScholarPubMed
Tyler, K. L., Sandberg, E., and Baum, K. F. 1994. Medical medullary syndrome and meningovascular syphilis: A case report in an HIV-infected man and a review of the literature. Neurology, 44, 2231–5.10.1212/WNL.44.12.2231CrossRefGoogle Scholar
Umashankar, G., Gupta, V., and Harik, S. I. 2004. Acute bilateral inferior cerebellar infarction in a patient with neurosyphilis. Arch Neurol, 61, 953–6.10.1001/archneur.61.6.953CrossRefGoogle Scholar
Vartdal, F., Vandvik, B., Michaelsen, T. E., Loe, K., and Norrby, E. 1982. Neurosyphilis: Intrathecal synthesis of oligoclonal antibodies to Treponema pallidum. Ann Neurol, 11, 35–40.10.1002/ana.410110107CrossRefGoogle ScholarPubMed
Vatz, K. A., Scheibel, R. L., Keiffer, S. A., and Ansari, K. A. 1974. Neurosyphilis and diffuse cerebral angiopathy: A case report. Neurology, 24, 472–6.10.1212/WNL.24.5.472CrossRefGoogle ScholarPubMed
Winstein, C. J., Stein, J., Arena, R., et al. Guidelines for adult stroke rehabilitation and recovery: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. 2016. Stroke, 47, e98–169.10.1161/STR.0000000000000098CrossRefGoogle ScholarPubMed
Wong, T., Fonesca, K., Chernesky, M.A., et al. 2015. Canadian Public Health Laboratory Network laboratory guidelines for the diagnosis of neurosyphilis in Canada. Can J Infect Dis Med Microbiol, 26 (suppl A), 18A–22A.10.1155/2015/167484CrossRefGoogle ScholarPubMed

References

Akalin, H., Akdis, A. C., and Mistik, R., et al. 1994. Cerebrospinal fluid interleukin-beta/interleukin-I receptor antagonist balance and tumor necrosis factor-alpha concentrations in tuberculous, viral and acute bacterial meningitis. Scand J Infect Dis, 26, 667–74.10.3109/00365549409008634CrossRefGoogle Scholar
Andronikou, S., Wilmshurst, J., Hatherill, M., and VanToorn, R. 2006. Distribution of brain infarction in children with tuberculous meningitis and correlation with outcome score at 6 months. Pediatr Radiol, 36, 1289–94.10.1007/s00247-006-0319-7CrossRefGoogle ScholarPubMed
Askanazy, M. 1910. (Quoted by Winkleman, N. W., and Moore, T. 1940. Meningeal blood vessels in tuberculous meningitis. Am Rev Tuberc, 42, 315–33).Google Scholar
Babu, G. N., Kumar, A., Kalita, J., and Misra, U. K. 2008. Proinflammatory cytokine levels in the serums and cerebrospinal fluid of tuberculous meningitis patients. Neurosc Lett, 436, 48–51.10.1016/j.neulet.2008.02.060CrossRefGoogle Scholar
Baumgarten, P. 1881. Gammose arteritis und entsprechende tuberculose veranderungen. Virchows Arch Pathol Anat Physiol Klin Med, 179, 86.Google Scholar
Berenguer, J., Moreno, S., Laguna, F. et al. 1992. Tuberculous meningitis in patients infected with the human immunodeficiency virus infection. N Engl J Med, 326, 668–72.10.1056/NEJM199203053261004CrossRefGoogle Scholar
Brancusi, F., Farrar, J., and Heemskerk, D. 2012. Tuberculous meningitis in adults: A review of a decade of developments focusing on prognostic factors for outcome. Future Microbiol, 7, 1101–16.10.2217/fmb.12.86CrossRefGoogle ScholarPubMed
Chen, P., Shi, M., Feng, G. D., et al. 2012. A highly efficient Ziehl–Neelsen stain: Identifying de novo intracellular Mycobacterium tuberculosis and improving detection of extracellular M. tuberculosis in cerebrospinal fluid. J Clin Microbiol, 50, 1166–70.10.1128/JCM.05756-11CrossRefGoogle ScholarPubMed
Collomb, H., Lemercier, G., Virieu, R., and Dumas, M. 1967. Multiple cerebral vascular thrombosis due to arteritis associated with tuberculous meningitis. Bulletin Societé Medecale d’Afriqu Noire de Langue Français, 12, 813–22.Google Scholar
Cotran, R. S., Kumar, V., and Collins, T. 1999. Diseases of immunity. In Robbins Pathological Basis of Disease, eds. Cotran, R. S., Kumar, V., and Collins., T. Philadelphia: W. B. Saunders, pp. 188–259.Google Scholar
Crithchley, J. A., Young, F., Orton, L., and Gamer, P. 2013. Corticosteroids for prevention of mortality in people with tuberculosis: A systemic review and meta-analysis. The Lancet, 13, 223–37.Google Scholar
Dalal, P. M. 1979. Observations on the involvement of cerebral vessels in tuberculous meningitis in adults. In Advances in Neurology, eds. Goldstein, M., Bolis, L., Fieschi, C., Gorini, S., and Millikan, C. H.. New York: Raven Press, vol. 25, pp. 149–59.Google Scholar
Dalal, P. M. and Dalal, K. P. 1989. Cerebrovascular manifestations of infectious disease. In Toole, J. F.., ed. Handbook of Clinical Neurology. Amsterdam: Elsevier, vol. 11, pp. 411–41.Google Scholar
Dastur, D. K. and Lalitha, V. S. 1973. The many facets of neurotuberculosis: An epitome of neuropathology. In Progress in Neuropathology, ed. Zimmerman, H.. New York: Grune and Stratton, pp. 351–408.Google Scholar
Dastur, D. K., Lalitha, V. S., Udani, P. M., and Parekh, U. 1970. The brain and meninges in TBM. Gross pathology and pathogenesis in 100 cases. Neurol India, 18, 86–100.Google Scholar
Denkinger, C. M., Schumacher, S. G., Boehme, C. C., et al. 2014. Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: systematic review and meta-analysis. Eur Respir J, 44, 435–46.10.1183/09031936.00007814CrossRefGoogle ScholarPubMed
Deshpande, D. H., Bharucha, E. P., and Mondkar, V. P. 1969. Tuberculous meningitis in adults. Neurol India, 17, 28–35.Google ScholarPubMed
Donald, P. R., Schoeman, J. F., Beyers, N., et al. 1995. Concentrations of interferon gamma, tumor necrosis factor alpha, and interleukin-I beta in the cerebrospinal fluid of children treated for tuberculous meningitis. Clin Infect Dis, 21, 924–9.10.1093/clinids/21.4.924CrossRefGoogle ScholarPubMed
Dube, M. P., Holton, P. D., and Larsen, R. A. 1992. Tuberculous meningitis in patients with and without human immunodeficiency virus infection. Am J Med, 93, 520–4.10.1016/0002-9343(92)90579-ZCrossRefGoogle ScholarPubMed
Hsieh, F., Chia, L., and Shen, W. 1992. Location of cerebral infarctions in tuberculous meningitis. Neuroradiology, 34, 197–9.10.1007/BF00596334CrossRefGoogle ScholarPubMed
Kalita, J., Misra, U. K., and Nair, P. P. 2009. Predictors of stroke and its significance in the outcome of tuberculous meningitis. J Stroke Cerebrovasc Dis, 18, 251–58.10.1016/j.jstrokecerebrovasdis.2008.11.007CrossRefGoogle ScholarPubMed
Kalita, J., Prasad, S., Maurya, P. K., Kumar, S., and Misra, U. K. 2012. MR angiography in tuberculous meningitis. Acta Radiol, 53, 324–29.10.1258/ar.2012.110712CrossRefGoogle ScholarPubMed
Katrak, S. M., Shembalkar, P. K., Bijwe, S. R., and Bhandarkar, L. D. 2000. The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human immunodeficiency virus infection. J Neurol Sci, 181, 118–26.10.1016/S0022-510X(00)00440-8CrossRefGoogle ScholarPubMed
Kawre, K. K., Satishchandra, P., Shankar, S. K., et al. 2001. Tuberculous meningitis with and without HIV infection. Abstracts of Annual Conference of Neurological Society of India, A225, 311–2.Google Scholar
Kingsley, D. P. E., Hendrickse, W. A., Kendall, B. E., et al. 1987. Tuberculous meningitis: Role of CT in management and prognosis. J Neurol Neurosurg Psychiatry, 50, 30–6.10.1136/jnnp.50.1.30CrossRefGoogle Scholar
Lammie, G. A., Hewlett, R. H., Schoeman, J. F., and Donald, P.R., 2009. Tuberculous cerebrovascular disease: A review. J Infect, 59, 156–66.10.1016/j.jinf.2009.07.012CrossRefGoogle ScholarPubMed
Lan, S. H., Chang, W. N., Lu, C. H., Lui, C. C., and Chang, H. W. 2001. Cerebral infarction in chronic meningitis: A comparison of tuberculous meningitis and cryptococcal meningitis. Q J Med, 94, 247–53.10.1093/qjmed/94.5.247CrossRefGoogle ScholarPubMed
Lehrer, H. 1966. The angiographic triad in tuberculous meningitis. Radiology, 87, 829.10.1148/87.5.829CrossRefGoogle ScholarPubMed
Mastroianni, C. M., Paoletti, F., Lichtner, M., D’Agostino, C., et al. 1997. Cerebrospinal fluid cytokines in patients with tuberculous meningitis. Clin Immunol Immunopathol, 84, 171–6.10.1006/clin.1997.4367CrossRefGoogle ScholarPubMed
Mishra, N. K. and Goyal, M. 1999. Imaging of CNS Tuberculosis in Neurology in Tropics, eds. Chopra, J. S., and Sawhney, I. M. S.. New Delhi: BI Churchill Livingstone Pvt. Ltd, pp. 370–90.Google Scholar
Misra, U. K., Kalita, J., and Maurya, P. K. 2011. Stroke in tuberculous meningitis. J Neurol Sci, 303, 22–30.10.1016/j.jns.2010.12.015CrossRefGoogle ScholarPubMed
Morse, D. 1961. Prehistoric TB in America. Am Rev Respir Dis, 83, 489.Google Scholar
Patel, V. B., Bhigjee, A. I., Bill, P. L. A., and Connolly, C. A. 2002. Cytokine profile in HIV seropositive patients with tuberculous meningitis. J Neurol Neurosurg Psychiatry, 73, 598–9.10.1136/jnnp.73.5.598CrossRefGoogle ScholarPubMed
Pienaar, M., Andronikou, S., and van Toorn, R. 2009. MRI to demonstrate diagnostic features and complications of TBM not seen with CT. Childs Nerv Syst, 25, 941–7.CrossRefGoogle Scholar
Poltera, A. A. 1977. Thrombogenic intracranial vasculitis in tuberculous meningitis. A 20 year post mortem survey. Acta Neurol Belg, 77, 112–24.Google ScholarPubMed
Porkert, M. T., Sotir, M., Parrott-Moore, P., and Blumberg, H. M. 1997. Tuberculous meningitis at a large inner city medical centre. Am J Med Sci, 313, 325–31.Google Scholar
Prasad, K., Singh, M. B., and Ryan, H. 2016. Corticosteroids for managing tuberculous meningitis. Cochrane Database System Rev, 4, 1–64.Google ScholarPubMed
Rich, A. R. and McCordock, H. A. 1933. The pathogenesis of tuberculous meningitis. Bull Johns Hopkins Hosp, 53, 5–37.Google Scholar
Rojas-Echeverri, L. A., Soto-Hernandez, J. L., and Garza, S., et al. 1996. Predictive value of digital subtraction angiography in patients with tuberculous meningitis. Neuroradiology, 38, 20–24.10.1007/BF00593210CrossRefGoogle ScholarPubMed
Shankar, S. K. 1989. CNS vasculopathy–revisited. In Progress in Clinical Neurosciences 5, eds. Sinha, K. K. and Chandra, P.. Ranchi: Neurological Society of India, Catholic Press, pp. 93–101.Google Scholar
Shukla, R., Abbas, A., Kumar, P., Gupta, R. K., et al. 2008. Evaluation of cerebral infarction in tuberculous meningitis by diffusion weighted imaging. J Infect, 57, 298–306.10.1016/j.jinf.2008.07.012CrossRefGoogle ScholarPubMed
Simmons, C. P., Thwaites, G. E., Quyen, N. T. et al., 2005. The clinical benefit of adjunctive dexamethasone in the tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses J Immunol, 175, 579–90.10.4049/jimmunol.175.1.579CrossRefGoogle ScholarPubMed
Singhal, B. S., Bhagwati, S. N., Sayed, A. H., and Laud, G. W. 1975. Raised intracranial pressure in tuberculous meningitis. Neurol India, 23, 32–9.Google ScholarPubMed
Sinha, H. P., Modi, M., Prabhakar, S., and Singh, P. 2015. Do cytokines correlate with disease activity in tuberculous meningitis? Neurology Asia, 20, 243–50.Google Scholar
Streptomycin in Tuberculosis Trial Committee. 1948. Medical Research Council streptomycin treatment of tuberculous meningitis. Lancet, 1, 582–96.Google Scholar
Sze, G. and Zimmerman, R. D. 1988. The magnetic resonance imaging of infections and inflammatory diseases. Radiol Clin North Am, 26, 839–59.CrossRefGoogle ScholarPubMed
Takahashi, T., Nakayama, T., and Tamura, M., et al. 2005. Nested polymerase chain reaction for assessing the clinical cause of tuberculous meningitis. Neurology, 64, 1789–93.10.1212/01.WNL.0000162052.13838.B2CrossRefGoogle ScholarPubMed
Thomas, M. D., Chopra, J. S., Banerjee, A. K., and Singh, M. S. 1997. Tuberculous meningitis: A clinicopathological study. Neurol India, 25, 26–34.Google Scholar
Thwaites, G. E., Bang, N. D., Dung, N. H., et al. 2004. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med, 351, 1741–51.10.1056/NEJMoa040573CrossRefGoogle ScholarPubMed
Thwaites, G. E., Macmullen-Price, J., Chau, T. T. H., and Mal, P. P., et al. 2007. Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: An observational study. Lancet Neurol, 6, 282–90.10.1016/S1474-4422(07)70034-0CrossRefGoogle ScholarPubMed
Thwaites, G. E., Bhavnani, S. M., and Chau, T. T., et al. 2011. Randomized pharmacokinetic and pharmacodynamics comparison of fluoroquinolones for tuberculous meningitis. Antimicrob Agents Chemother, 55, 3244–53.10.1128/AAC.00064-11CrossRefGoogle ScholarPubMed
Udani, P. M., Parekh, U. C., and Dastur, D. K. 1971. Neurological and related syndromes in CNS tuberculosis: Clinical features and pathogenesis. J Neurol Sci, 14, 341–57.10.1016/0022-510X(71)90222-XCrossRefGoogle ScholarPubMed
Vashishta, R. K. and Banerjee, A. K. 1999. CNS Tuberculosis – Pathology. In Neurology in Tropics, eds. Chopra, J. S., and Sawhney, I. M. S.. New Delhi: BI Churchill Livingstone Pvt. Ltd, pp. 391–8.Google Scholar
Villora, M. F., Fortea, F., Moreno, S., et al. 1995. MR imaging and CT of central nervous system tuberculosis in patients with AIDS. Radiol Clin North Am, 33, 805–20.Google Scholar
Wadia, N. H. and Singhal, B. S. 1967. Cerebral arteriography in tuberculous meningitis. Neurol India, 25, 127–32.Google Scholar
Winkleman, N. W. and Moore, T. 1940. Meningeal blood vessels in tuberculous meningitis. Am Rev Tuberc, 42, 315–33.Google Scholar
WHO, 2014. Global Tuberculosis Report 2014. Geneva: World Health Organization.Google Scholar
Yamashima, T., Kashihara, K., Ikeda, K., Kubota, T., and Yamamoto, S. 1985. Three phases of cerebral arteriopathy in meningitis: Vasospasm and vasodilatation followed by organic stenosis. Neurosurgery, 16, 546–53.Google ScholarPubMed
Yechoor, V. K., Shandera, W. X., Rodriguez, P., and Cate, T. R. 1990. Tuberculous meningitis among adults with or without HIV infection. Arch Intern Med, 156, 1710–6.Google Scholar

References

Antinori, S., Corbellino, M., Meroni, L., et al. 2013. Aspergillus meningitis: A rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases. J Infection, 66, 218–38.CrossRefGoogle ScholarPubMed
Arsura, E. L., Johnson, R., Penrose, J., et al. 2005. Neuroimaging as a guide to predict outcomes for patients with coccidioidal meningitis. Clin Inf Dis, 40, 624–27.CrossRefGoogle ScholarPubMed
Asari, S., Nishimoto, A., and Murakami, M. 1988. A rare case of cerebral Aspergillus aneurysm at the site of the temporary clip application. No Shinkie Geka, 16, 1079–82.Google ScholarPubMed
Baddley, J. W., Salzman, D., and Pappas, P. G. 2002. Fungal brain abscess in transplant recipients: Epidemiologic, microbiologic, and clinical features. Clin Transplant, 16, 419–24.10.1034/j.1399-0012.2002.02033.xCrossRefGoogle ScholarPubMed
Bariola, J. R., Perry, P., Pappas, P. G., et al. 2010. Blastomycosis of the central nervous system: A multicenter review of diagnosis and treatment in the modern era. Clin Inf Dis, 50, 797–804.10.1086/650579CrossRefGoogle ScholarPubMed
Beal, M. F., O’Carroll, C. P., Kleinman, G. M., and Grossman, R. I. 1982. Aspergillosis of the central nervous system. Neurology, 32, 473–9.10.1212/WNL.32.5.473CrossRefGoogle Scholar
Bodey, G., Bueltman, B., Duguid, W., et al. 1992. Fungal infections in cancer patients: An international autopsy survey. Eur J Clin Microbiol Infect Dis, 11, 99–109.CrossRefGoogle ScholarPubMed
Boes, B., Bashir, R., Boes, C., et al. 1994. Central nervous system aspergillosis: Analysis of 26 cases. J Neuroimaging, 4, 123–9.10.1111/jon199443123CrossRefGoogle Scholar
Bor, D. H., Woolhandler, S., Nardin, R., Brusch, J., and Himmelstein, D. U. 2013. Infective endocarditis in the U.S., 1998–2009: A nationwide study. PLoS One, 8, e60033.10.1371/journal.pone.0060033CrossRefGoogle ScholarPubMed
Breadmore, R., Desmond, P., and Opeskin, K. 1994. Intracranial aspergillosis producing cavernous sinus syndrome and rupture of the internal carotid artery. Australas Radiol, 38, 795–7.10.1111/j.1440-1673.1994.tb00134.xCrossRefGoogle Scholar
Burgert, S. J., Classen, D. C., Burke, J. P., and Blatter, D. D. 1995. Candidal brain abscess associated with vascular invasion: A devastating complication of vascular catheter-related candidemia. Clin Inf Dis, 21, 202–5.10.1093/clinids/21.1.202CrossRefGoogle ScholarPubMed
Cachia, D., Singh, C., Tetzlaff, M.T., Penas-Prado, M. 2015. Middle cerebral artery territory infarct due to cryptococcus infections: An uncommon indication for cerebrospinal fluid analysis in stroke patients. Diagn Cytopath, 43, 632–4.10.1002/dc.23219CrossRefGoogle ScholarPubMed
Cimbaluk, D., Scudiere, J., Butsch, J., and Jakate, S. 2005. Invasive candidal enterocolitis followed shortly by fatal cerebral hemorrhage in immunocompromised patients. J Clin Gastroenterol, 39, 795–7.10.1097/01.mcg.0000177237.82382.b8CrossRefGoogle ScholarPubMed
Cleri, D. J., Moser, R. L., Viollota, F. J., et al. 2003. Pulmonary aspergillosis and central nervous system hemorrhage as complications of hemolytic anemia treated with corticosteroids. South Med J, 96, 592–5.10.1097/01.SMJ.0000056645.47125.96CrossRefGoogle ScholarPubMed
Coplin, W. M., Cochran, M. S., Levine, S. R., and Crawford, S. W. 2001. Stroke after bone marrow transplantation: Frequency, aetiology and outcome. Brain, 124, 1043–51.10.1093/brain/124.5.1043CrossRefGoogle ScholarPubMed
Corvisier, N., Gray, F., Cherardi, R., et al. 1987. Aspergillosis of ethmoid sinus and optic nerve, with arteritis and rupture of the internal carotid artery. Surg Neurol, 28, 311–5.10.1016/0090-3019(87)90312-0CrossRefGoogle ScholarPubMed
de Almeida, S. M., Querioz-Telles, F., Tieve, H. A., Ribeiro, C. E., and Wernek, L. C. 2004. Central nervous system paracoccidiomycosis: clinical features and laboratorial findings. J Infect, 48, 193–8.10.1016/j.jinf.2003.08.012CrossRefGoogle Scholar
de Medeiros, C. R., Bleggi-Torre, L. F., Faoro, L. N., et al. 2001. Cavernous sinus thrombosis caused by zygomycosis after unrelated bone marrow transplantation. Transplant Infectious Diseases, 3, 231–4.Google ScholarPubMed
de Pauw, B. D. E. and Meunier, F. 1999. The challenge of invasive fungal infections. Chemotherapy, 45(suppl.), 1–14.10.1159/000048465CrossRefGoogle Scholar
Dooley, D. P., Hollsten, D. A., Grimes, S. R., and Moss, J. Jr. 1992. Indolent orbital apex syndrome caused by occult mucormycosis. J Clin Neuroophthalmol, 12, 245–9.Google ScholarPubMed
Ebright, J. R., Pace, M. T., and Niazi, A. F. 2001. Septic thrombosis of the cavernous sinuses. Arch Intern Med, 161, 2671–6.10.1001/archinte.161.22.2671CrossRefGoogle ScholarPubMed
Endo, T., Tominaga, T., Konno, H., and Yoshimoto, T. 2002. Fatal subarachnoid hemorrhage, brainstem and cerebellar infarction, caused by aspergillus infection after cerebral aneurysm surgery: Case report. Neurosurgery, 50, 1147–51.Google ScholarPubMed
Ermak, D., Kanekar, S., Specht, C. S., Wojnar, M., and Lowden, M. 2014. Looks like a stroke, acts like a stroke, but it’s more than a stroke: A case of cerebral mucormycosis. J Stroke Cerebrovasc Dis, 23, e403–4.10.1016/j.jstrokecerebrovasdis.2014.02.024CrossRefGoogle Scholar
Eucker, J., Sezer, O., Graf, B., and Possinger, K. 2001. Mucormycoses. Mycoses, 44, 253–60.10.1111/j.1439-0507.2001.00656.xCrossRefGoogle ScholarPubMed
Fu, K. A., Nguyen, P. L., and Sanossian, N. 2015. Basilar artery territory stroke secondary to invasive fungal sphenoid sinusitis: A case report. Case Rep Neurol, 7, 51–8.10.1159/000380761CrossRefGoogle Scholar
Gabelmann, A., Klein, S., Kern, W., et al. 2007. Relevant imaging findings of cerebral aspergillosis on MRI: A retrospective case-based study in immunocompromised patients. Eur J Neurol, 14, 548–55.10.1111/j.1468-1331.2007.01755.xCrossRefGoogle ScholarPubMed
Germain, M., Gourdeau, M., and Hebert, J. 1994. Case report: Familial chronic mucocutaneous candidiasis complicated by deep candida infection. Am J Med Sci, 307, 282–3.10.1097/00000441-199404000-00008CrossRefGoogle ScholarPubMed
Girishkumar, H., Yousuf, A. M., Ghivate, J., and Geisler, E. 1999. Experience with invasive candida infections. Postgrad Med J, 75, 151–2.CrossRefGoogle ScholarPubMed
Gollard, R., Rabb, C., Larsen, R., and Chandrasoma, P. 1994. Isolated cerebral mucormycosis: Case report and therapeutic considerations. Neurosurgery, 34, 174–7.Google ScholarPubMed
Gonzalez-Duarte, A., Calleja, J. H., Mitre, V. G., and Ramos, G. G. 2009. Simultaneous central nervous system complications of C. neoformans infection. Neurology Intl, 1, 82–3.10.4081/ni.2009.e22CrossRefGoogle ScholarPubMed
Grouhi, M., Ilan, D., Misbet-Brown, E., and Roifman, C. M., 1998. Cerebral vasculitis associated with chronic mucocutaneous candidiasis. J Pediatr, 133, 571–4.10.1016/S0022-3476(98)70072-1CrossRefGoogle ScholarPubMed
Hall, W. A. and Nussbaum, E. S. 1995. Isolated cerebral mucormycosis: Case report and therapeutic considerations [correspondence]. Neurosurgery, 36, 623.Google ScholarPubMed
Haran, R. P., Chandy, M. J. 1993. Intracranial aspergillus granuloma. Br J Neurosurg, 7, 383–88.10.3109/02688699309103492CrossRefGoogle ScholarPubMed
Ihara, K., Makita, Y., Nabeshima, S., Tei, T., Keyaki, A., and Kioka, H. 1990. Aspergillosis of the central nervous system causing subarachnoid hemorrhage from mycotic aneurysm of the basilar artery: Case report. Neurol Med Chir, 30, 618–23.10.2176/nmc.30.618CrossRefGoogle Scholar
Kameh, D. S. and Gonzalez, O. R. 1997. Fatal rhino-orbital-cerebral zygomycosis. South Med J, 90, 1133–7.10.1097/00007611-199711000-00015CrossRefGoogle ScholarPubMed
Khan, M. U., Ali, S., Baig, M. A., et al. 2007. Candida parapsilosis endocarditis 8 months after transient candidemia. Int J Cardiol, 118, e58–e59.CrossRefGoogle ScholarPubMed
Kieburtz, K. D., Eskin, T. A., Ketonen, T. A., and Tuite, M. J. 1993. Opportunistic cerebral vasculopathy and stroke in patients with acquired immunodeficiency syndrome. Arch Neurol, 50, 430–2.10.1001/archneur.1993.00540040082019CrossRefGoogle ScholarPubMed
Kleinschmidt-DeMasters, B. K. 2002. Central nervous system aspergillosis: A 20-year retrospective series. Hum Pathol, 33, 116–24.10.1053/hupa.2002.30186CrossRefGoogle ScholarPubMed
Koc, Z., Koc, F., Yerdelen, D., and Ozdogu, H. 2007. Rhino-orbital-cerebral mucormycosis with different cerebral involvements: Infarct, hemorrhage, and ophthalmoplegia. Int J Neurosci, 117, 1677–90.10.1080/00207450601050238CrossRefGoogle ScholarPubMed
Lan, S. H., Chang, W. N., Lu, C. H., Liu, C. C., and Chang, H.W. 2001. Cerebral infarction in chronic meningitis: a comparison of tuberculous meningitis and cryptococcal meningitis. Q J Med, 94, 247–53.10.1093/qjmed/94.5.247CrossRefGoogle ScholarPubMed
Lass-Florl, C. D., Griff, K., Mayr, A., et al. 2005. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br J Haematol, 312, 201–7.Google Scholar
Lau, A. H., Takeshita, M., and Ishii, N. 1991. Mycotic (aspergillus) arteritis resulting in fatal subarachnoid hemorrhage: A case report. Angiology, 42, 251–5.10.1177/000331979104200310CrossRefGoogle ScholarPubMed
Li, C. S., Huang, C. R., Lu, C. H., Lui, C. C., Chien, C. C., and Chang, W. N. 2004. Concomitant stroke and candida parapsilosis native valve endocarditis: report of one case and literature review. Acta Neurol Taiwan, 13, 131–5.Google ScholarPubMed
Lipton, S. A., Hickey, S. F., Morris, J. H., and Loscalzo, J. 1984. Candidal infection in the central nervous system. Am J Med, 76, 101–8.10.1016/0002-9343(84)90757-5CrossRefGoogle ScholarPubMed
Liu, Z. Y., Sheng, R. Y., Li, D. L., Li, T. S., and Wang, A. X. 2003. Nosocomial fungal infections, analysis of 149 cases. Zhonghua Yi Xue Za Zhi, 83, 399–403.Google ScholarPubMed
Mathur, S. C., Friedman, H. D., Kende, A. J., Davis, R. L., and Graziano, S. L. 1999. Cryptic mucor infection leading to massive cerebral infarction at initiation of antileukemic chemotherapy. Ann Hematol, 78, 241–5.10.1007/s002770050509CrossRefGoogle ScholarPubMed
Matsumura, S., Sato, S., Fujiwara, H., et al. 1988. Cerebral aspergillosis as a cerebrovascular accident. Brain Nerve, 40, 225–32.Google Scholar
Munksgaard, B. 2004. Fungal infections. Am J Transplant, 4 (suppl. 10), 110–34.Google Scholar
Munoz, J., Hughes, A., and Guo, Y. 2013. Mucormycosis-associated intracranial hemorrhage. Blood Coag and Fibrinolysis, 24, 100–1.10.1097/MBC.0b013e32835a72dfCrossRefGoogle ScholarPubMed
Murthy, J. M., Sundaram, C., Prasad, V. S., et al. 2000. Aspergillosis of the central nervous system: A study of 21 patients seen in a university hospital in south India. J Assoc Physicians India, 48, 677–81.Google Scholar
Nguyen, F. N., Kar, J. K., Zakaria, A., and Schiess, M. C. 2013. Isolated central nervous system histoplasmosis presenting with ischemic pontine stroke and meningitis in an immune-competent patient. JAMA Neurol, 70, 638–41.10.1001/jamaneurol.2013.1043CrossRefGoogle Scholar
Oner, A. Y., Celik, H., Akpek, S., and Tokgoz, N. 2006. Central nervous system aspergillosis: Magnetic resonance imaging, diffusion-weighted imaging, and magnetic resonance spectroscopy features. Acta Radiologica, 47, 408–12.10.1080/02841850600580325CrossRefGoogle ScholarPubMed
Pagano, L., Ricci, P., Montillo, M., et al. 1996. Localization of aspergillosis to the central nervous system among patients with acute leukemia: A report of 14 cases. Gruppo Italiano Malattie Ematologiche dell’Adulto Infection Program. Clin Infect Dis, 23, 628–30.10.1093/clinids/23.3.628CrossRefGoogle Scholar
Parker, J. C., McCloskey, J. J., and Lee, R.S. 1981. Human cerebral candidosis: A postmoretem analysis of 19 patients. Human Path, 12, 23–8.10.1016/S0046-8177(81)80238-9CrossRefGoogle Scholar
Piotrowski, W. P. and Pilz, P. 1994. Postoperative fungal arteritis mimicking vasospasm. Neurol Medic Chir, 34, 315–8.Google ScholarPubMed
Rangel-Guerra, R., Martinez, H. R., Saenz, C. Bosques-Padilla, F., and Estrada-Bellman, I. 1996. Rhinocerebral and system mycormycosis. Clinical experience with 36 cases. J Neurol Sci, 143, 19–30.10.1016/S0022-510X(96)00148-7CrossRefGoogle Scholar
Roger, P. M., Boissy, C., Gari-Toussaint, M., et al. 2000. Medical treatment of a pacemaker endocarditis due to Candida albicans and to Candida glabrate. J Inf, 41, 176–8.10.1053/jinf.2000.0640CrossRefGoogle Scholar
Rogers, L. R. 2003. Cerebrovascular complications in cancer patients. Neurol Clin, 21, 167–92.10.1016/S0733-8619(02)00066-XCrossRefGoogle ScholarPubMed
Rosario, M., Song, S. X., and McCullough, L. D. 2012. An unusual case of stroke. Neurologist, 18, 229–32.10.1097/NRL.0b013e31825bbf4dCrossRefGoogle ScholarPubMed
Saul, R. F., Gallagher, J. G., and Mateer, J.E. 1986. Sudden hemiparesis as the presenting sign in cryptococcal meningoencephalitis. Stroke, 17, 753–4.10.1161/01.STR.17.4.753CrossRefGoogle Scholar
Scharf, E. L., Cloft, H. J., and Wijdicks, E. 2016. Mucor thrombus. Neurocrit Care, 24, 268–72.10.1007/s12028-015-0186-xCrossRefGoogle ScholarPubMed
Smith, R. M., Schaefer, M. K., Kainer, M. A., et al. 2013. Fungal infections associated with contaminated methylprednisolone injections. N Engl J Med, 369, 1598–609.10.1056/NEJMoa1213978CrossRefGoogle ScholarPubMed
Sun, X. L., Zhang, J., Wang, G. G, et al. 2013 Comparison of characteristics and short-term outcome from fungal infective endocarditis in prosthetic valve endocarditis versus native valve endocarditis. Am J Cardiol, 112, 111–6.10.1016/j.amjcard.2013.02.068CrossRefGoogle ScholarPubMed
Sundaram, C., Mahadevan, A., Laxmi, V. et al. 2005. Cerebral zygomycosis. Mycoses, 48, 396–407.10.1111/j.1439-0507.2005.01167.xCrossRefGoogle ScholarPubMed
Suzuki, K., Iwabuchi, N., Kuramochi, S. et al. 1995. Aspergillus aneurysm of the middle cerebral artery causing a fatal subarachnoid hemorrhage. Intern Med, 34, 550–3.10.2169/internalmedicine.34.550CrossRefGoogle ScholarPubMed
Takahashi, Y., Sugita, Y., Maruiwa, H., et al. 1998. Fatal hemorrhage from rupture of the intracranial internal carotid artery caused by aspergillus arteritis. Neurosurg Rev, 21, 198–201.10.1007/BF02389333CrossRefGoogle ScholarPubMed
Terol, J. J., Tassies, D., Lopez-Guillermon, A., et al. 1994. Sepsis by Candida tropicalis in patients with granulocytopenia: A study of 10 cases. Med Clin (Barc), 103, 579–82.Google ScholarPubMed
Torres-Cisneros, J., Lopez, O. L., Kusne, S., et al. 1993. CNS aspergillosis in organ transplantation: A clinicopathologic study. J Neurol, Neurosurg, Psychiatry, 56, 188–93.Google Scholar
Verma, A., Brozman, B., and Petito, C. K. 2005. Isolated cerebral mucormycosis: Report of a case and review of the literature. J Neurol Sci, 240, 65–9.Google ScholarPubMed
Vilchez, R. A., Fung, J., and Kusne, S. 2002. Cryptococcosis in organ transplant recipients: An overview. Am J Transplant, 2, 576–80.10.1034/j.1600-6143.2002.20701.xCrossRefGoogle ScholarPubMed
Walshe, T. J., Hier, D. B., and Caplan, L. R. 1985a. Aspergillosis of the central nervous system: Clinicopathological analysis of 17 patients. Ann Neurol, 18, 574–82.Google Scholar
Walshe, T. J., Hier, D. B., and Caplan, L. R. 1985b. Fungal infections of the central nervous system: Comparative analysis of risk factors and clinical signs. Neurology, 35, 1654–7.Google Scholar
Zalduondo, F. M., Provenzale, J. M., Hulette, C., and Gorecki, J. P. 1996. Meningitis, vasculitis, and cerebritis caused by CNS histoplasmosis: Radiologic–pathologic correlation. Am J Radiol, 166, 194–6.Google ScholarPubMed
Zhang, R., Zhang, J. W., and Szerlip, H. M. 2002. Endocarditis and hemorrhagic stroke caused by Cunninghamella bertholletiae infection after kidney transplantation. Am J Kidney Dis, 40, 842–6.10.1053/ajkd.2002.35698CrossRefGoogle ScholarPubMed

References

Aditya, G. S., Mahadevan, A., Santosh, V., et al. 2004. Cysticercal chronic basal arachnoiditis with infarcts, mimicking tuberculous pathology in endemic areas. Neuropathology, 24, 320–5.10.1111/j.1440-1789.2004.00564.xCrossRefGoogle ScholarPubMed
Alarcón, F., Hidalgo, F., Moncayo, J., Viñán, I., and Dueñas, G. 1992a. Cerebral cysticercosis and stroke. Stroke, 23, 224–8.10.1161/01.STR.23.2.224CrossRefGoogle ScholarPubMed
Alarcón, F., Vanormelingen, K., Moncayo, J., and Viñán, I. 1992b. Cerebral cysticercosis as a risk factor for stroke in young and middle-aged people. Stroke, 23, 1563–5.10.1161/01.STR.23.11.1563CrossRefGoogle Scholar
Arteaga-Rodríguez, C., Naréssi-Munhoz, A. H., and Hernández-Fustes, O. J. 2004. Infarto cerebral extenso y neurocisticercosis. Rev Neurol, 39, 583.10.33588/rn.3906.2004303CrossRefGoogle Scholar
Asenjo, A. 1950. Setenta y dos casos de cisticercosis en el instituto de neurocirugía. Revista de Neuro-Psiquiatría, 13, 337–53.Google Scholar
Bang, O. Y., Heo, J. H., Choi, S. A., and Kim, D. I. 1997. Large cerebral infarction during praziquantel therapy in neurocysticercosis. Stroke, 28, 211–3.10.1161/01.STR.28.1.211CrossRefGoogle ScholarPubMed
Barinagarrementería, F. 1989. Causas no aterosclerosas de isquemia cerebral. Arch Inst Nac Neurol Neurocir Mex, 4 (suppl), 33.Google Scholar
Barinagarrementería, F. and Cantú, C. 1992. Neurocysticercosis as a cause of stroke. Stroke, 23, 1180–1.10.1161/01.STR.23.8.1180CrossRefGoogle ScholarPubMed
Barinagarrementería, F. and Cantú, C. 1998. Frequency of cerebral arteritis in subarachnoid cysticercosis. An angiographic study. Stroke, 29, 123–5.10.1161/01.STR.29.1.123CrossRefGoogle ScholarPubMed
Barinagarrementeria, F. and Del Brutto, O. H. 1988a. Neurocysticercosis and pure motor hemiparesis. Stroke, 19, 1156–8.10.1161/01.STR.19.9.1156CrossRefGoogle ScholarPubMed
Barinagarrementeria, F. and Del Brutto, O. H. 1988b. Ataxic hemiparesis from parenchymal brain cysticercosis. J Neurol, 235, 325.10.1007/BF00314186CrossRefGoogle ScholarPubMed
Barinagarrementeria, F. and Del Brutto, O. H. 1989. Lacunar syndrome due to neurocysticercosis. Arch Neurol, 46, 415–7.10.1001/archneur.1989.00520400075022CrossRefGoogle ScholarPubMed
Barinagarrementeria, F., Del Brutto, O. H., and Otero, E. 1988. Ataxic hemiparesis from cysticercosis. Arch Neurol, 45, 246.10.1001/archneur.1988.00520270016010CrossRefGoogle Scholar
Bouldin, A., and Pinter, J. D. 2006. Resolution of arterial stenosis in a patient with periarterial neurocysticercosis treated with oral prednisone. J Child Neurol, 21, 1064–7.10.1177/7010.2006.00132CrossRefGoogle Scholar
Cantú, C. and Barinagarrementería, F. 1996. Cerebrovascular complications of neurocysticercosis. Clinical and neuroimaging spectrum. Arch Neurol, 53, 233–9.10.1001/archneur.1996.00550030039021CrossRefGoogle ScholarPubMed
Cantú, C., Villarreal, J., Soto, J. L., and Barinagarrementeria, F. 1998. Cerebral cysticercotic arteritis: Detection and follow-up by transcranial Doppler. Cerebrovasc Dis, 8, 2–7.10.1159/000015808CrossRefGoogle ScholarPubMed
Cardenas, G., Guevara-Silva, E., Fleury, A., Sciutto, E., and Soto-Hernandez, J. L. 2012. Subarachnoid hemorrhage in neurocysticercosis. A direct or serendipitous association? Neurologist, 18, 324–38.10.1097/NRL.0b013e31826754fdCrossRefGoogle ScholarPubMed
Catapano, M. S. and Marx, J. A. 1986. Central nervous system cysticercosis simulating an acute cerebellar hemorrhage. Ann Emerg Med, 15, 847–9.10.1016/S0196-0644(86)80389-4CrossRefGoogle ScholarPubMed
Del Brutto, O. H. 1992. Cysticercosis and cerebrovascular disease: A review. J Neurol Neurosurg Psychiatry, 55, 252–4.10.1136/jnnp.55.4.252CrossRefGoogle ScholarPubMed
Del Brutto, O. H. 1997a. Albendazole therapy for subarachnoid cysticerci: Clinical and neuroimaging analysis of 17 patients. J Neurol Neurosurg Psychiatry, 62, 659–61.10.1136/jnnp.62.6.659CrossRefGoogle ScholarPubMed
Del Brutto, O. H. 1997b. Clues to prevent cerebrovascular hazards of cysticidal drug therapy. Stroke, 28, 1088.Google ScholarPubMed
Del Brutto, O. H. 2005. Neurocysticercosis. Semin Neurol, 25, 243–51.10.1055/s-2005-917661CrossRefGoogle ScholarPubMed
Del Brutto, O. H. 2012. Neurocysticercosis among international travelers to disease-endemic areas. J Travel Med, 19, 112–710.1111/j.1708-8305.2011.00592.xCrossRefGoogle ScholarPubMed
Del Brutto, O. H., Lama, J., for the Atahualpa Project Investigators. 2013. The importance of neurocysticercosis in stroke in rural areas of a developing Latin American country. Am J Trop Med Hyg, 89, 374–5.10.4269/ajtmh.13-0196CrossRefGoogle ScholarPubMed
Del Brutto, O. H., Sotelo, J., Aguirre, R., Diaz-Calderon, E., and Alarcón, T. A. 1992. Albendazole therapy for giant subarachnoid cysticerci. Arch Neurol, 49, 535–8.Google ScholarPubMed
Del Brutto, O. H. and Garcia, H. H. 2014. Cysticercosis of the human nervous system. Heildelberg: Springer-Verlag.10.1007/978-3-642-39022-7CrossRefGoogle Scholar
Dolpogol, V. B. and Neustaedter, M. 1935. Meningo-encephalitis caused by Cysticercus cellulosae. Arch Neurol Psychiatry, 33, 132–47.Google Scholar
Eboli, P., Drazin, D., Bannykh, S. I., and Schievink, W. 2012. Surgical management and role of medical therapy in unruptured aneurysmal neurocysticercosis. A case report and review of the literature. Neuroradiol J, 25, 337–41.10.1177/197140091202500309CrossRefGoogle Scholar
Escobar, A. and Weidenheim, K. M. 2002. The pathology of neurocysticercosis. In Taenia Solium Cysticercosis. From Basic to Clinical Science, eds. Singh, G., and Prabhakar, S.. Oxford: CAB International, pp. 289–305.10.1079/9780851996288.0289CrossRefGoogle Scholar
García, H. H., Nash, T. E., and Del Brutto, O. H. 2014. Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurol, 13, 1202–15.10.1016/S1474-4422(14)70094-8CrossRefGoogle ScholarPubMed
García, H. H., Evans, C. A. W., Nash, T. E., et al. 2002. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev, 15, 747–56.10.1128/CMR.15.4.747-756.2002CrossRefGoogle ScholarPubMed
Gauthier, N., Sangla, S., Stroh-Marcy, A., and Payen, L. 1995. Neurocysticercose révélée par un accident vasculaire cérébral. J Radiol, 76, 119–23.Google Scholar
Guevara-Dondé, J. E., Gadea-Nieto, M. S., and Gómez-Llata, A. S. 1987. Cisticerco recubriendo un aneurisma de la arteria basilar. Arch Inst Nac Neurol Neurocir Mex, 2, 41–2.Google Scholar
Henneberg, R. 1912. Die tierischen parasiten des zentralnervensystems. I. Des Cysticercus cellulosae. In Handbuch der Neurologie, Vol III, Spezielle Neurologie II, ed. Lewandowsky, M.. Berlin: Verlag von Julius Springer, pp. 642–83.Google Scholar
Huang, P. P., Choudhri, H. F., Jallo, G., and Miller, D. C. 2000. Inflammatory aneurysm and neurocysticercosis: Further evidence for a causal relationship? Case report. Neurosurgery, 47, 466–7.10.1097/00006123-200008000-00042CrossRefGoogle ScholarPubMed
Jha, S. and Kumar, V. 2000. Neurocysticercosis presenting as stroke. Neurol India, 48, 391–4.Google ScholarPubMed
Kim, I. Y., Kim, T. S., Lee, J. H., et al. 2005. Inflammatory aneurysm due to neurocysticercosis. J Clin Neurosci, 12, 585–8.10.1016/j.jocn.2004.07.018CrossRefGoogle ScholarPubMed
Kohli, A., Gupta, R., and Kishore, J. 1997. Anterior cerebral artery infarction in neurocysticercosis: Evaluation by MR angiography and in vivo proton MR spectroscopy. Pediatr Neurosurg, 26, 93–6.10.1159/000121169CrossRefGoogle ScholarPubMed
Lee, S. I. and Chang, G. Y. 1998. Recurrent brainstem transient ischemic attacks due to neurocysticercosis: A treatable cause. Eur Neurol, 40, 174–5.Google ScholarPubMed
Levy, A. S., Lillehei, K. O., Rubinstein, D., and Stears, J. C. 1995. Subarachnoid neurocysticercosis with occlusion of the major intracranial arteries: Case report. Neurosurgery, 36, 183–8.Google ScholarPubMed
McCormick, G. F., Giannotta, S., Zee, C. S., and Fisher, M. 1983. Carotid occlusion in cysticercosis. Neurology, 33, 1078–80.10.1212/WNL.33.8.1078CrossRefGoogle ScholarPubMed
Moniz, E., Loff, R., and Pacheco, L. 1932. Sur le diagnostic de la cysticercose cérébrale. L’Encephale, 27, 42–53.Google Scholar
Marquez, J. M. and Arauz, A. 2012. Cerebrovascular complications of neurocysticercosis. Neurologist 18, 17–22.CrossRefGoogle ScholarPubMed
Monteiro, L., Almeida-Pinto, J., Leite, I., Xavier, J., and Correia, M. 1994. Cerebral cysticercus arteritis: Five angiographic cases. Cerebrovasc Dis, 4, 125–33.10.1159/000108468CrossRefGoogle Scholar
Murrell, K. D. 2005. WHO/FAO/OIE Guidelines for the Surveillance, Prevention and Control of Taeniosis/Cysticercosis. Paris: Office International des Epizooties.Google Scholar
Pittella, J. E. H. 1997. Neurocysticercosis. Brain Pathol, 7, 681–93.10.1111/j.1750-3639.1997.tb01083.xCrossRefGoogle ScholarPubMed
Rocha, M. S. G., Brucki, S. M. D., Ferraz, A. C., and Piccolo, A. C. 2001. Doença cerebrovascular e neurocisticercose. Arq Neuropsiquiatr, 59, 778–83.10.1590/S0004-282X2001000500023CrossRefGoogle Scholar
Rodriguez-Carbajal, J., Del Brutto, O. H., Penagos, P., Huebe, J., and Escobar, A. 1989. Occlusion of the middle cerebral artery due to cysticercotic angiitis. Stroke, 20, 1095–9.10.1161/01.STR.20.8.1095CrossRefGoogle ScholarPubMed
Soto-Hernández, J. L., Gomez-Llata, S. A., Rojas-Echeverri, L. A., et al. 1996. Subarachnoid hemorrhage secondary to a ruptured inflammatory aneurysm. A possible complication of neurocysticercosis: Case report. Neurosurgery, 38, 197–9.10.1097/00006123-199601000-00045CrossRefGoogle Scholar
Tellez-Zenteno, J. F., Negrete-Pulido, O. R., Cantú, C., et al. 2003. Hemorrhagic stroke associated to neurocysticercosis. Neurología, 18, 272–5.Google ScholarPubMed
terPenning, B., Litchman, C. D., and Heier, L. 1992. Bilateral middle cerebral artery occlusions in neurocysticercosis. Stroke, 23, 280–3.10.1161/01.STR.23.2.280CrossRefGoogle ScholarPubMed
Trelles, J. O. and Ravens, R. 1953. Estudios sobre neurocisticercosis. II. Lesiones vasculares, meníngeas, ependimarias y neuró glicas. Revista de Neuro-Psiquiatría, 16, 241–70.Google Scholar
Viola, G. M., White, C. Jr., and Serpa, J. A. 2012. Hemorrhagic cerebrovascular events of neurocysticercosis: A case report and review of the literature. Am J Trop Med Hyg, 84, 402–5.Google Scholar
Wallin, M. T. and Kurtzke, J. F. 2004. Neurocysticercosis in the United States. Review of an important emerging infection. Neurology, 63, 1559–64.10.1212/01.WNL.0000142979.98182.FFCrossRefGoogle ScholarPubMed
Woo, E., Yu, Y. L., and Huang, C. Y. 1988. Cerebral infarct precipitated by praziquantel in neurocysticercosis: A cautionary note. Trop Geogr Neurol, 40, 143–6.Google ScholarPubMed
Wraige, E., Graham, J., Robb, S. A., and Jan, W. 2003. Neurocysticercosis masquerading as a cerebral infarct. J Child Neurol, 18, 298–300.10.1177/08830738030180040501CrossRefGoogle ScholarPubMed

References

Antonara, S., Ristow, L., and Coburn, J. (2011). Adhesion mechanisms of Borrelia burgdorferi. Adv Exp Med Biol 715: 35–49.10.1007/978-94-007-0940-9_3CrossRefGoogle ScholarPubMed
Back, T., Grunig, S., Winter, Y., et al. (2013). Neuroborreliosis-associated cerebral vasculitis: Long-term outcome and health-related quality of life. J Neurol 260: 1569–75.10.1007/s00415-013-6831-4CrossRefGoogle ScholarPubMed
Banerjee, A., Kim, B. J., Carmona, E. M., et al. (2011). Bacterial Pili exploit integrin machinery to promote immune activation and efficient blood-brain barrier penetration. Nat Commun 2: 462.10.1038/ncomms1474CrossRefGoogle ScholarPubMed
Berglund, J., Eitrem, R., Ornstein, K., et al. (1995). An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med 333: 1319–27.10.1056/NEJM199511163332004CrossRefGoogle ScholarPubMed
Bodilsen, J., Dalager-Pedersen, M., Schonheyder, H. C., and Nielsen, H. (2014). Stroke in community-acquired bacterial meningitis: A Danish population-based study. Int J Infect Dis 20: 18–22.10.1016/j.ijid.2013.12.005CrossRefGoogle ScholarPubMed
Brogan, G. X., Homan, C. S., and Viccellio, P. (1990). The enlarging clinical spectrum of Lyme disease: Lyme cerebral vasculitis, a new disease entity. Ann Emerg Med 19: 572–6.10.1016/S0196-0644(05)83017-3CrossRefGoogle ScholarPubMed
Brouqui, P., Bacellar, F., Baranton, G., et al. (2004). Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin Microbiol Infect 10: 1108–32.10.1111/j.1469-0691.2004.01019.xCrossRefGoogle ScholarPubMed
CDC ( (2015a). Pneumococcal disease. Retrieved October 25, 2015 from http://www.cdc.gov/pneumococcal/clinicians/clinical-features.html.Google Scholar
CDC (2015b). Meningococcal Disease: Technical & Clinical Information. Retrieved October 25, 2015, 2015, from http://www.cdc.gov/meningococcal/clinical-info.html.Google Scholar
CDC (2015c). Group B strep (GBS). Retrieved October 25, 2015 from http://www.cdc.gov/groupbstrep/clinicians/clinical-overview.html.Google Scholar
CDC (2015d). Listeria (Listeriosis). Retrieved October 25, 2015, from http://www.cdc.gov/listeria/statistics.html.Google Scholar
Chehrenama, M., Zagardo, M., and Koski, C. (1997). Subarachnoid hemorrhage in a patient with Lyme disease. Neurology 48: 520–3.10.1212/WNL.48.2.520CrossRefGoogle Scholar
Cheshier, R., Tu, E., Glaser, C., et al. (2003). Outbreaks of aseptic meningitis associated with echoviruses 9 and 30 and preliminary surveillance reports on enterovirus activity – United States, 2003. MMWR 52: 761–4.Google Scholar
Corral, I., Quereda, C., Guerrero, A., Escudero, R., and Marti-Belda, P. (1997). Neurological manifestations in patients with sera positive for Borrelia burgdorferi. Neurologia 12: 2–8.Google Scholar
Cox, M. G., Wolfs, T. F., Lo, T. H., Kappelle, L. J., and Braun, K. P. (2005). Neuroborreliosis causing focal cerebral arteriopathy in a child. Neuropediatrics 36: 104–7.10.1055/s-2005-837573CrossRefGoogle ScholarPubMed
Deloizy, M., Devos, P., Stekelorom, T., Testard, D., and Belhadia, A. (2000). Left sided sudden hemiparesis linked to a central form of Lyme disease. Rev Neurol (Paris) 156: 1154–6.Google ScholarPubMed
Halperin, J. J. (2003). Lyme disease and the peripheral nervous system. Muscle & Nerve 28: 133–43.10.1002/mus.10337CrossRefGoogle ScholarPubMed
Halperin, J., Logigian, E., Finkel, M., and Pearl, R. (1996). Practice parameter for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Neurology 46: 619–27.10.1212/WNL.46.3.619CrossRefGoogle ScholarPubMed
Hammers-Berggren, S., Grondahl, A., Karlsson, M., et al. (1993). Screening for neuroborreliosis in patients with stroke. Stroke 24: 1393–6.10.1161/01.STR.24.9.1393CrossRefGoogle ScholarPubMed
Hanny, P. E. and Hauselmann, H. J. (1987). Die Lyme-Krankheit aus der Sicht des Neurologen. Schwiez med Wsch 117: 901–15.Google Scholar
Heinrich, A., Khaw, A. V., Ahrens, N., Kirsch, M., and Dressel, A. (2003). Cerebral vasculitis as the only manifestation of Borrelia burgdorferi infection in a 17-year-old patient with basal ganglia infarction. Eur Neurol 50: 109–12.10.1159/000072510CrossRefGoogle Scholar
Henriksen, T. B. (1997). Lyme neuro-borreliosis in a 66-year old women. Differential diagnosis of cerebral metastases and cerebral infarction. Ugeskr Laeger 159: 3175–7.Google Scholar
Jacobi, C., Schwark, C., Kress, B., et al. (2006). Subarachnoid hemorrhage due to Borrelia burgdorferi-associated vasculitis. Eur J Neurol 13: 536.10.1111/j.1468-1331.2006.01335.xCrossRefGoogle ScholarPubMed
Kastenbauer, S. and Pfister, H. W. (2003). Pneumococcal meningitis in adults: Spectrum of complications and prognostic factors in a series of 87 cases. Brain 126: 1015–25.10.1093/brain/awg113CrossRefGoogle Scholar
Keil, R., Baron, R., Kaiser, R., and Deuschl, G. (1997). Vasculitis course of neuroborreliosis with thalamic infarct. Nervenarzt 68: 339–41.Google ScholarPubMed
Klein, M., Koedel, U., Pfefferkorn, T., et al. (2011). Arterial cerebrovascular complications in 94 adults with acute bacterial meningitis. Crit Care 15: R281.10.1186/cc10565CrossRefGoogle ScholarPubMed
Klingebiel, R., Benndorf, G., Schmitt, M., von Moers, A., and Lehmann, R. (2002). Large cerebral vessel occlusive disease in Lyme neuroborreliosis. Neuropediatrics 33: 37–40.10.1055/s-2002-23589CrossRefGoogle ScholarPubMed
Koedel, U., Scheld, W. M., and Pfister, H. W. (2002). Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis 2: 721–36.10.1016/S1473-3099(02)00450-4CrossRefGoogle ScholarPubMed
Kohler, J., Kern, U., Kasper, J., Rhese-Kupper, B., and Thoden, U. (1988). Chronic central nervous system involvement in Lyme borreliosis. Neurology 38: 863–7.10.1212/WNL.38.6.863CrossRefGoogle ScholarPubMed
Kurian, M., Pereira, V. M., Vargas, M. I., and Fluss, J. (2015). Stroke-like phenomena revealing multifocal cerebral vasculitis in pediatric Lyme neuroborreliosis. J Child Neurol 30: 1226–9.10.1177/0883073814552104CrossRefGoogle ScholarPubMed
Laroche, C., Lienhardt, A., and Boulesteix, J. (1999). Ischemic stroke caused by neuroborreliosis. Arch Pediatr 6: 1302–5.Google ScholarPubMed
Lebas, A., Toulgoat, F., Saliou, G., Husson, B., and Tardieu, M. (2012). Stroke due to Lyme neuroborreliosis: Changes in vessel wall contrast enhancement. J Neuroimaging 22: 210–12.10.1111/j.1552-6569.2010.00550.xCrossRefGoogle ScholarPubMed
Li, S., Vytopil, M., Hreib, K., and Craven, D. E. (2015). Lyme disease presenting as multiple ischaemic strokes. Pract Neurol 15: 284–8.10.1136/practneurol-2014-001072CrossRefGoogle ScholarPubMed
May, E. F. and Jabbari, B. (1990). Stroke in neuroborreliosis. Stroke 21: 1232–5.10.1161/01.STR.21.8.1232CrossRefGoogle ScholarPubMed
Midgard, R. and Hofstad, H. (1987). Unusual manifestations of nervous system Borrelia burgdorferi infection. Arch Neurol 44: 781–3.10.1001/archneur.1987.00520190085021CrossRefGoogle ScholarPubMed
Mygland, A., Ljostad, U., Fingerle, V., et al. (2010). EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 17: 8–16, e11–14.10.1111/j.1468-1331.2009.02862.xCrossRefGoogle ScholarPubMed
Nagel, M. A. and Gilden, D. (2015). The relationship between herpes zoster and stroke. Curr Neurol Neurosci Rep 15: 16.10.1007/s11910-015-0534-4CrossRefGoogle ScholarPubMed
Oksi, J., Kalimo, H., Marttila, R. J., et al. (1996). Inflammatory brain changes in Lyme borreliosis. A report on three patients and review of literature. Brain 119: 2143–54.10.1093/brain/119.6.2143CrossRefGoogle ScholarPubMed
Oksi, J., Kalimo, H., Marttila, R. J., et al. (1998). Intracranial aneurysms in three patients with disseminated Lyme borreliosis: Cause or chance association? J Neurol Neurosurg Psychiatry 64: 636–42.10.1136/jnnp.64.5.636CrossRefGoogle ScholarPubMed
Olarte, L., Barson, W. J., Barson, R. M., et al. (2015). Impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in US children. Clin Infect Dis 61: 767–75.10.1093/cid/civ368CrossRefGoogle ScholarPubMed
Olsson, J. E. and Zbornikova, V. (1990). Neuroborreliosis simulating a progressive stroke. Acta Neurol Scand 81: 471–4.Google ScholarPubMed
Orihuela, C. J., Mahdavi, J., Thornton, J., et al. (2009). Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models. J Clin Invest 119: 1638–46.10.1172/JCI36759CrossRefGoogle ScholarPubMed
Reik, L. Jr. (1993). Stroke due to Lyme disease. Neurology 43: 2705–7.10.1212/WNL.43.12.2705CrossRefGoogle ScholarPubMed
Renard, C., Marignier, S., Gillet, Y., et al. (2008). Acute hemiparesis revealing a neuroborreliosis in a child. Arch Pediatr 15: 41–4.Google ScholarPubMed
Rey, V., Du Pasquier, R., Muehl, A., Peter, O., and Michel, P. (2010). Multiple ischemic strokes due to Borrelia garinii meningovasculitis. Rev Neurol (Paris) 166: 931–4.10.1016/j.neurol.2010.03.010CrossRefGoogle ScholarPubMed
Roberts, E. D., Bohm, R. P. Jr., Lowrie, R. C. Jr., et al. (1998). Pathogenesis of Lyme neuroborreliosis in the rhesus monkey: The early disseminated and chronic phases of disease in the peripheral nervous system. J Infect Dis 178: 722–32.10.1086/515357CrossRefGoogle ScholarPubMed
Romi, F., Krakenes, J., Aarli, J. A., and Tysnes, O. B. (2004). Neuroborreliosis with vasculitis causing stroke-like manifestations. Eur Neurol 51: 49–50.10.1159/000075090CrossRefGoogle ScholarPubMed
Roos, K. J., Tunkel, A. R., van de Beek, D., and Scheld, M. (2014). Acute bacterial meningitis. In Infections of the Central Nervous Systtem, eds. Scheld, M., Whitley, J. W. and Marra, C. M.. Philadelphia: Wolters Kluwer Health.Google Scholar
Scheid, R., Hund-Georgiadis, M., and von Cramon, D. Y. (2003). Intracerebral haemorrhage as a manifestation of Lyme neuroborreliosis? Eur J Neurol 10: 99–101.10.1046/j.1468-1331.2003.00541.xCrossRefGoogle ScholarPubMed
Schmiedel, J., Gahn, G., von Kummer, R., and Reichmann, H. (2004). Cerebral vasculitis with multiple infarcts caused by Lyme disease. Cerebrovasc Dis 17: 79–81.10.1159/000073904CrossRefGoogle ScholarPubMed
Schmitt, A. B., Kuker, W., and Nacimiento, W. (1999). Neuroborreliosis with extensive cerebral vasculitis and multiple cerebral infarcts. Nervenarzt 70: 167–71.Google ScholarPubMed
Schoen, F. J. (2005). Blood vessels. In Robbins & Cotran, Pathologic Basis of Disease, eds. Kumar, V., Abbas, A. K. and Fausto, N.. Elsevier Saunders: pp. 511–537.Google Scholar
Schuchat, A. (1998). Epidemiology of group B streptococcal disease in the United States: Shifting paradigms. Clin Microbiol Rev 11: 497–513.10.1128/CMR.11.3.497CrossRefGoogle Scholar
Schut, E. S., Brouwer, M. C., de Gans, J., et al. (2009). Delayed cerebral thrombosis after initial good recovery from pneumococcal meningitis. Neurology 73: 1988–95.10.1212/WNL.0b013e3181c55d2eCrossRefGoogle ScholarPubMed
Seijo Martinez, M., Grandes Ibanez, J., Sanchez Herrero, J., and Garcia-Monco, J. C. (2001). Spontaneous brain hemorrhage associated with Lyme neuroborreliosis. Neurologia 16: 43–5.Google ScholarPubMed
Smeeth, L., Thomas, S. L., Hall, A. J., et al. (2004). Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 351: 2611–18.10.1056/NEJMoa041747CrossRefGoogle ScholarPubMed
Sparsa, L., Blanc, F., Lauer, V., et al. (2009). Recurrent ischemic strokes revealing Lyme meningovascularitis. Rev Neurol (Paris) 165: 273–7.Google ScholarPubMed
Thigpen, M. C., Whitney, C. G., Messonnier, N. E., et al. (2011). Bacterial meningitis in the United States, 1998–2007. N Engl J Med 364: 2016–25.10.1056/NEJMoa1005384CrossRefGoogle ScholarPubMed
Topakian, R., Stieglbauer, K., Nussbaumer, K., and Aichner, F. T. (2008). Cerebral vasculitis and stroke in Lyme neuroborreliosis. Two case reports and review of current knowledge. Cerebrovasc Dis 26: 455–61.10.1159/000155982CrossRefGoogle ScholarPubMed
Uldry, P. A., Regli, F., and Bogousslavsky, J. (1987). Cerebral angiopathy and recurrent strokes following Borrelia burgdorferi infection. J Neurol Nsurg & Psych 50: 1703–4.Google ScholarPubMed
Van Snick, S., Duprez, T. P., Kabamba, B., Van De Wyngaert, F. A., and Sindic, C. J. (2008). Acute ischaemic pontine stroke revealing lyme neuroborreliosis in a young adult. Acta Neurol Belg 108: 103–6.Google ScholarPubMed
Veenendaal-Hilbers, J. A., Perquin, W. V., Hoogland, P. H. and Doornbos, L. (1988). Basal meningovasculitis and occlusion of the basilar artery in two cases of Borrelia burgdorferi infection. Neurology 38: 1317–19.10.1212/WNL.38.8.1317CrossRefGoogle ScholarPubMed
Walsh, J. G., Muruve, D. A., and Power, C. (2014). Inflammasomes in the CNS. Nat Rev Neurosci 15: 84–97.10.1038/nrn3638CrossRefGoogle ScholarPubMed
Wilke, M., Eiffert, H., Christen, H. J., and Hanefeld, F. (2000). Primarily chronic and cerebrovascular course of Lyme neuroborreliosis: Case reports and literature review. Arch Dis Child 83: 67–71.10.1136/adc.83.1.67CrossRefGoogle ScholarPubMed
Wittwer, B., Pelletier, S., Ducrocq, X., et al. (2015). Cerebrovascular events in Lyme neuroborreliosis. J Stroke Cerebrovasc Dis 24: 1671–8.10.1016/j.jstrokecerebrovasdis.2015.03.056CrossRefGoogle ScholarPubMed
Wormser, G. P., Dattwyler, R. J., Shapiro, E. D., et al. (2006). The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 43: 1089–134.10.1086/508667CrossRefGoogle ScholarPubMed
Zhang, Y., Lafontant, G., and Bonner, F. J. Jr. (2000). Lyme neuroborreliosis mimics stroke: A case report. Arch Phys Med Rehabil 81: 519–21.10.1053/mr.2000.4431CrossRefGoogle ScholarPubMed

References

Kawasaki, T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 16, 178–222 (1967).Google ScholarPubMed
Bell, D. M., Morens, D. M., Holman, R. C., Hurwitz, E. S., & Hunter, M. K. Kawasaki syndrome in the United States 1976 to 1980. Am J Dis Child 137, 211–14 (1983).10.1001/archpedi.1983.02140290003001CrossRefGoogle ScholarPubMed
Ferro, J. M. Vasculitis of the central nervous system. J Neurol 245, 766–76 (1998).10.1007/s004150050285CrossRefGoogle ScholarPubMed
Morens, D. M. & O’Brien, R. J. Kawasaki disease in the United States. J Infect Dis 137, 91–93 (1978).Google ScholarPubMed
Amano, S. & Hazama, F. Neural involvement in Kawasaki disease. Acta Pathol Jpn 30, 365–73 (1980).Google Scholar
Amano, S., Hazama, F., & Hamashima, Y. Pathology of Kawasaki disease: II. Distribution and incidence of the vascular lesions. Jpn Circ J 43, 741–8 (1979).10.1253/jcj.43.741CrossRefGoogle ScholarPubMed
Tanaka, S., Sagiuchi, T., & Kobayashi, I. Ruptured pediatric posterior cerebral artery aneurysm 9 years after the onset of Kawasaki disease: A case report. Childs Nerv Syst 23, 701–6 (2007).10.1007/s00381-006-0263-8CrossRefGoogle ScholarPubMed
Shulman, S. T. & Rowley, A. H. Etiology and pathogenesis of Kawasaki disease. Progress in Pediatric Cardiology 6, 187–92 (1997).10.1016/S1058-9813(97)00189-6CrossRefGoogle Scholar
Yanagawa, H., et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics 107, E33 (2001).10.1542/peds.107.3.e33CrossRefGoogle ScholarPubMed
Yanagawa, H., et al. Incidence of Kawasaki disease in Japan: The nationwide surveys of 1999–2002. Pediatr Int 48, 356–61 (2006).10.1111/j.1442-200X.2006.02221.xCrossRefGoogle ScholarPubMed
Burns, J. C., et al. Kawasaki disease: A brief history. Pediatrics 106, E27 (2000).10.1542/peds.106.2.e27CrossRefGoogle ScholarPubMed
Kawasaki, T., Kosaki, F., Okawa, S., Shigematsu, I., & Yanagawa, H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 54, 271–6 (1974).10.1542/peds.54.3.271CrossRefGoogle ScholarPubMed
Newburger, J. W., et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114, 1708–33 (2004).10.1542/peds.2004-2182CrossRefGoogle Scholar
Cheung, Y. F., et al. Inflammatory gene polymorphisms and susceptibility to Kawasaki disease and its arterial sequelae. Pediatrics 122, e608–14 (2008).10.1542/peds.2008-0646CrossRefGoogle ScholarPubMed
Jackson, J. L., Kunkel, M. R., Libow, L., & Gates, R. H. Adult Kawasaki disease. Report of two cases treated with intravenous gamma globulin. Arch Intern Med 154, 1398–405 (1994).10.1001/archinte.1994.00420120130014CrossRefGoogle ScholarPubMed
Rauch, A. M. Kawasaki syndrome: Issues in etiology and treatment. Adv Pediatr Infect Dis 4, 163–82 (1989).Google ScholarPubMed
Chang, R. K. Hospitalizations for Kawasaki disease among children in the United States, 1988–1997. Pediatrics 109, e87 (2002).10.1542/peds.109.6.e87CrossRefGoogle ScholarPubMed
Dillon, M. J. & Ozen, S. A new international classification of childhood vasculitis. Pediatr Nephrol 21, 1219–22 (2006).10.1007/s00467-006-0181-8CrossRefGoogle ScholarPubMed
Ozen, S., et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 65, 936–41 (2006).10.1136/ard.2005.046300CrossRefGoogle ScholarPubMed
Amano, S., Hazama, F., & Hamashima, Y. Pathology of Kawasaki disease: I. Pathology and morphogenesis of the vascular changes. Jpn Circ J 43, 633–43 (1979).10.1253/jcj.43.633CrossRefGoogle ScholarPubMed
Amano, S., et al. General pathology of Kawasaki disease. On the morphological alterations corresponding to the clinical manifestations. Acta Pathol Jpn 30, 681–94 (1980).Google ScholarPubMed
Mason, W. H., Burns, J. C. Clinical presentation of Kawasaki disease. Progress in Pediatric Cardiology 6, 193–201 (1997).10.1016/S1058-9813(97)00190-2CrossRefGoogle Scholar
Dajani, A. S., et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 87, 1776–80 (1993).10.1161/01.CIR.87.5.1776CrossRefGoogle ScholarPubMed
Newburger, J. W., et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 110, 2747–71 (2004).10.1161/01.CIR.0000145143.19711.78CrossRefGoogle Scholar
Newburger, J. W., Burns, J. C., Beiser, A. S., & Loscalzo, J. Altered lipid profile after Kawasaki syndrome. Circulation 84, 625–31 (1991).10.1161/01.CIR.84.2.625CrossRefGoogle ScholarPubMed
Dengler, L. D., et al. Cerebrospinal fluid profile in patients with acute Kawasaki disease. Pediatr Infect Dis J 17, 478–81 (1998).10.1097/00006454-199806000-00008CrossRefGoogle ScholarPubMed
Tabarki, B., Mahdhaoui, A., Selmi, H., Yacoub, M., & Essoussi, A. S. Kawasaki disease with predominant central nervous system involvement. Pediatr Neurol 25, 239–41 (2001).10.1016/S0887-8994(01)00290-9CrossRefGoogle ScholarPubMed
Terasawa, K., Ichinose, E., Matsuishi, T., & Kato, H. Neurological complications in Kawasaki disease. Brain Dev 5, 371–4 (1983).10.1016/S0387-7604(83)80041-2CrossRefGoogle ScholarPubMed
Bailie, N. M., Hensey, O. J., Ryan, S., Allcut, D., & King, M.D. Bilateral subdural collections–an unusual feature of possible Kawasaki disease. Eur J Paediatr Neurol 5, 79–81 (2001).10.1053/ejpn.2001.0469CrossRefGoogle ScholarPubMed
Fujiwara, S., Yamano, T., Hattori, M., Fujiseki, Y., & Shimada, M. Asymptomatic cerebral infarction in Kawasaki disease. Pediatr Neurol 8, 235–6 (1992).10.1016/0887-8994(92)90077-CCrossRefGoogle ScholarPubMed
Knott, P. D., Orloff, L. A., Harris, J. P., Novak, R. E., & Burns, J.C. Sensorineural hearing loss and Kawasaki disease: A prospective study. Am J Otolaryngol 22, 343–8 (2001).10.1053/ajot.2001.26495CrossRefGoogle ScholarPubMed
Koutras, A. Myositis with Kawasaki’s disease. Am J Dis Child 136, 78–9 (1982).Google ScholarPubMed
Lapointe, J. S., Nugent, R. A., Graeb, D. A., & Robertson, W. D. Cerebral infarction and regression of widespread aneurysms in Kawasaki’s disease: Case report. Pediatr Radiol 14, 1–5 (1984).10.1007/BF02386720CrossRefGoogle ScholarPubMed
Laxer, R. M., Dunn, H. G., & Flodmark, O. Acute hemiplegia in Kawasaki disease and infantile polyarteritis nodosa. Dev Med Child Neurol 26, 814–18 (1984).10.1111/j.1469-8749.1984.tb08176.xCrossRefGoogle ScholarPubMed
Suda, K., Matsumura, M., & Ohta, S. Kawasaki disease complicated by cerebral infarction. Cardiol Young 13, 103–5 (2003).10.1017/S1047951103000179CrossRefGoogle ScholarPubMed
Tanaka, S., Sagiuchi, T., & Kobayashi, I. Ruptured pediatric posterior cerebral artery aneurysm 9 years after the onset of Kawasaki disease: A case report. Childs Nerv Syst 23, 701–6 (2007).10.1007/s00381-006-0263-8CrossRefGoogle ScholarPubMed
Templeton, P. A. & Dunne, M. G. Kawasaki syndrome: Cerebral and cardiovascular complications. J Clin Ultrasound 15, 483–5 (1987).10.1002/jcu.1870150711CrossRefGoogle ScholarPubMed
Wada, Y., Kamei, A., Fujii, Y., Ishikawa, K., & Chida, S. Cerebral infarction after high-dose intravenous immunoglobulin therapy for Kawasaki disease. J Pediatr 148, 399–400 (2006).10.1016/j.jpeds.2005.10.027CrossRefGoogle ScholarPubMed
Sabatier, I., et al. Stroke by carotid artery complete occlusion in Kawasaki disease: Case report and review of literature. Pediatr Neurol 49, 469–73 (2013).10.1016/j.pediatrneurol.2013.08.011CrossRefGoogle ScholarPubMed
Boespflug, O., Tardieu, M., Losay, J., & Leroy, D. Acute hemiplegia complicating Kawasaki disease. Rev Neurol (Paris) 140, 507–9 (1984).Google ScholarPubMed
Hosaki, J., Abe, S., Shoback, B. R., Yoshimatu, A., & Migita, T. Mucocutaneous lymph node syndrome with various arterial lesions. Helv Paediatr Acta 33, 127–33 (1978).Google ScholarPubMed
Lauret, P., Lecointre, C., & Billard, J. L. Kawasaki disease complicated by thrombosis of the internal carotid artery. Ann Dermatol Venereol 106, 901–5 (1979).Google ScholarPubMed
Beiser, A. S., Takahashi, M., Baker, A. L., Sundel, R. P., & Newburger, J. W. A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group. Am J Cardiol 81, 1116–20 (1998).Google ScholarPubMed
Muneuchi, J., et al. Magnetic resonance studies of brain lesions in patients with Kawasaki disease. Brain Dev 28, 30–3 (2006).10.1016/j.braindev.2005.04.003CrossRefGoogle ScholarPubMed
Ahn, J. H., Phi, J. H., Kang, H. S. et al., J Neurosurg Pediatric 6, 150–153 (2010).10.3171/2010.5.PEDS1012CrossRefGoogle Scholar
Ichiyama, T., et al. Cerebral hypoperfusion during acute Kawasaki disease. Stroke 29, 1320–1 (1998).10.1161/01.STR.29.7.1320CrossRefGoogle ScholarPubMed
Sato, T., et al. Kawasaki disease-associated MERS: Pathological insights from SPECT findings. Brain Dev 34, 605–8 (2012).10.1016/j.braindev.2011.09.015CrossRefGoogle ScholarPubMed
Takanashi, J., et al. Kawasaki disease complicated by mild encephalopathy with a reversible splenial lesion (MERS). J Neurol Sci 315, 167–9 (2012).10.1016/j.jns.2011.11.022CrossRefGoogle Scholar
Benseler, S. M., et al. Primary central nervous system vasculitis in children. Arthritis Rheum 54, 1291–7 (2006).10.1002/art.21766CrossRefGoogle ScholarPubMed
Kato, H., Koike, S., & Yokoyama, T. Kawasaki disease: Effect of treatment on coronary artery involvement. Pediatrics 63, 175–9 (1979).10.1542/peds.63.2.175CrossRefGoogle ScholarPubMed
Newburger, J. W., et al. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med 356, 663–75 (2007).10.1056/NEJMoa061235CrossRefGoogle ScholarPubMed
Newburger, J. W., et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315, 341–7 (1986).10.1056/NEJM198608073150601CrossRefGoogle ScholarPubMed
Newburger, J. W., et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324, 1633–9 (1991).10.1056/NEJM199106063242305CrossRefGoogle ScholarPubMed
Furusho, K., et al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 2, 1055–8 (1984).Google ScholarPubMed
Sundel, R. & Newburger, J. W. Management of acute Kawasaki disease. Progress in Pediatric Cardiology 6, 203–9 (1997).10.1016/S1058-9813(97)00191-4CrossRefGoogle Scholar
Alehan, F. K., Boyvat, F., Baskin, E., Derbent, M., & Ozbek, N. Focal cerebral vasculitis and stroke after chickenpox. Eur J Paediatr Neurol 6, 331–3 (2002).10.1053/ejpn.2002.0622CrossRefGoogle ScholarPubMed
deVeber, G., Roach, E. S., Riela, A. R., & Wiznitzer, M. Stroke in children: Recognition, treatment, and future directions. Semin Pediatr Neurol 7, 309–17 (2000).10.1053/spen.2000.20074CrossRefGoogle ScholarPubMed
Takeoka, M. & Takahashi, T. Infectious and inflammatory disorders of the circulatory system and stroke in childhood. Curr Opin Neurol 15, 159–64 (2002).10.1097/00019052-200204000-00006CrossRefGoogle ScholarPubMed
Israels, S. J. & Michelson, A. D. Antiplatelet therapy in children. Thromb Res 118, 75–83 (2006).10.1016/j.thromres.2004.12.016CrossRefGoogle ScholarPubMed
Bayers, S., Shulman, S. T., & Paller, A. S. Kawasaki disease: Part II. Complications and treatment. J Am Acad Dermatol 69, 513 e511–518 (2013).10.1016/j.jaad.2013.06.040CrossRefGoogle Scholar

References

Antunes, AF, Maduro, SG, Pereira, BV, et al. Chronic heart disease after treatment of oral acute Chagas disease. Arq Bras Cardiol 2016;107:184–6.Google ScholarPubMed
Aras, R, da Matta, JA, Mota, G, et al. Cerebral infarction in autopsies of chagasic patients with heart failure. Arq Bras Cardiol 2003;81:414–16.10.1590/S0066-782X2003001200008CrossRefGoogle ScholarPubMed
Aufderheide, AC, Salo, W, Madden, M, et al. A 9,000 year record of Chagas’ disease. Proc Natl Acad Sci USA 2004;101:2034–9.10.1073/pnas.0307312101CrossRefGoogle ScholarPubMed
Basquiera, AL, Sembaj, A, Aguerri, AM, et al. Risk progression to chronic Chagas cardiomyopathy: Influence of male sex and of parasitaemia detected by polymerase chain reaction. Heart 2003;89:1186–90.10.1136/heart.89.10.1186CrossRefGoogle ScholarPubMed
Belisario Falchetto, E, Costa, SC, Rochitte, CE. Diagnostic challenges of Chagas cardiomyopathy and CMR imaging. Glob Heart 2015;10:181–7.10.1016/j.gheart.2015.07.005CrossRefGoogle Scholar
Benaim, G, Paniz Mondolfi, AE. The emerging role of amiodarone and dronedarone in Chagas disease. Nat Rev Cardiol 2012;9:605–9.10.1038/nrcardio.2012.108CrossRefGoogle ScholarPubMed
Benedictus, MR, Leeuwis, AE, Binnewijzend, MA, et al. Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer’s disease. Eur Radiol 2016; in press.10.1007/s00330-016-4450-zCrossRefGoogle Scholar
Benvenuti, LA, Roggério, A, Freitas, HF, et al. Chronic American trypanosomiasis: Parasite persistence in endomyocardial biopsies is associated with high-grade myocarditis. Ann Trop Med Parasitol 2008;102:481–7.10.1179/136485908X311740CrossRefGoogle ScholarPubMed
Bern, C. Chagas disease in the immunosuppressed host. Cur Opin Infect Dis 2012;25:450–7.Google ScholarPubMed
Bern, C. Chagas’ disease. N Engl J Med 2015;373:456–66.10.1056/NEJMra1410150CrossRefGoogle ScholarPubMed
Bern, C, Montgomery, SP. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 2009;49:e52–4.10.1086/605091CrossRefGoogle Scholar
Bern, C, Martin, DL, Gilman, RH. Acute and congenital Chagas disease. Adv Parasitol 2011;75:19–47.10.1016/B978-0-12-385863-4.00002-2CrossRefGoogle ScholarPubMed
Bestetti, RB, Freitas, OC, Muccillo, G, et al. Clinical and morphological characteristics associated with sudden cardiac death in patients with Chagas’ disease. Eur Heart J 1993;14:1610–14.10.1093/eurheartj/14.12.1610CrossRefGoogle ScholarPubMed
Bestetti, RB, Restini, CB, Couto, LB. Carlos Chagas discoveries as a drop back to scientific construction of chronic Chagas heart disease. Arq Bras Cardiol 2016;107:63–70.Google Scholar
Braga, J, Labrunie, A, Villaça, F, et al. Thromboembolism in chronic Chagas’ heart disease. São Paulo Med J 1995;113:862–6.10.1590/S1516-31801995000200019CrossRefGoogle ScholarPubMed
Braga, JC, Reis, F, Aras, R, et al. Clinical and therapeutics aspects of heart failure due to Chagas disease. Arq Bras Cardiol 2006;86:297–302.10.1590/S0066-782X2006000400010CrossRefGoogle ScholarPubMed
Braggion-Santos, MF, Volpe, GJ, Pazin-Filho, A, et al. Sudden cardiac death in Brazil: A community-based autopsy series (2006–2010). Arq Bras Cardiol 2015;104:120–7.Google Scholar
Cardoso, AV, Lescano, SA, Amato Neto, V, et al. Survival of Trypanosoma cruzi in sugar cane used to prepare juice. Rev Inst Med Trop Sao Paulo 2006;48:287–9.10.1590/S0036-46652006000500009CrossRefGoogle ScholarPubMed
Carod-Artal, FJ. Stroke: A neglected complication of American trypanosomiasis (Chagas’ disease). Trans R Soc Trop Med Hyg 2007;1–1:1075–80.Google Scholar
Carod-Artal, FJ. Policy implications of the changing epidemiology of Chagas disease and stroke. Stroke 2013;44:2356–60.10.1161/STROKEAHA.113.000738CrossRefGoogle Scholar
Carod-Artal, FJ, Vargas, AP, Melo, M, et al. American trypanosomiasis (Chagas’ disease): An unrecognized cause of stroke. J Neurol Neurosurg Psychiatry 2003;74:516–18.10.1136/jnnp.74.4.516CrossRefGoogle Scholar
Carod-Artal, FJ, Vargas, AP, Horan, TA, et al. Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease. Stroke 2005;36:965–70.10.1161/01.STR.0000163104.92943.50CrossRefGoogle ScholarPubMed
Chagas, C. Nova tripanozomiaze humana. Estudo sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n.gen. n.sp., ajente etiolojico de nova entidade morbida do homem. Mem Inst Oswaldo Cruz 1909; 1:159–218.10.1590/S0074-02761909000200008CrossRefGoogle Scholar
Cougo-Pinto, PT, dos Santos, BL, Dias, FA, et al. Safety of IV thrombolysis in acute ischemic stroke related to Chagas disease. Neurology 2013;81:1773–5.10.1212/01.wnl.0000435566.30728.beCrossRefGoogle ScholarPubMed
Corral, RS, Guerrero, NA, Cuervo, H, et al. Trypanosoma cruzi infection and endothelin-1 cooperatively activate pathogenic inflammatory pathways in cardiomyocytes. PLoS Negl Trop Dis 2013;7:e2034.10.1371/journal.pntd.0002034CrossRefGoogle ScholarPubMed
da Matta, JA, Aras, R Jr, de Macedo, CR, et al. Stroke correlates in chagasic and non-chagasic cardiomyopathies. PLoS One 2012;7:e35116.10.1371/journal.pone.0035116CrossRefGoogle ScholarPubMed
de Andrade, AL de, Zicker, F, de Oliveira, RM, et al. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet 1996;348:1407–13.Google ScholarPubMed
Dias, JC. The indeterminate form of human chronic Chagas’ disease. A clinical epidemiological review. Rev Soc Bras Med Trop 1989;22:147–56.10.1590/S0037-86821989000300007CrossRefGoogle ScholarPubMed
Dias, JC. Evolution of Chagas disease screening programs and control programs: Historical perspective. Glob Heart 2015;10:193–202.10.1016/j.gheart.2015.06.003CrossRefGoogle Scholar
Dias, JC, Silveira, AC, Schofield, CJ. The impact of Chagas disease control in Latin America: A review. Mem Inst Oswaldo Cruz 2002;97:603–12.10.1590/S0074-02762002000500002CrossRefGoogle Scholar
Dias, JO Jr, da Costa Rocha, MO, de Souza, AC, et al. Assessment of the source of ischemic cerebrovascular events in patients with Chagas disease. Int J Cardiol 2014;176:1352–4.Google Scholar
Forsyth, CJ, Hernandez, S, Olmedo, W et al. Safety profile of nifurtimox for treatment of Chagas disease in the United States. Clin Infect Dis 2016;63:1056–62.10.1093/cid/ciw477CrossRefGoogle Scholar
Gurgel, CB, Ferreira, MC, Mendes, CR, et al. Apical lesions in Chagas’ heart disease patients: An autopsy study. Rev Soc Bras Med Trop 2010;43:709–12.Google ScholarPubMed
Jesus, PA, Neville, I, Cincura, C, et al. Stroke history and Chagas disease are independent predictors of silent cerebral microembolism in patients with congestive heart failure. Cerebrovasc Dis 2011;31:19–23.10.1159/000319892CrossRefGoogle ScholarPubMed
Kalil Filho, R, de Albuquerque, CP. Magnetic resonance imaging in Chagas heart disease. São Paulo Med J 1995;113:880–3.10.1590/S1516-31801995000200022CrossRefGoogle ScholarPubMed
Kuehn, BM. Chagas heart disease an emerging concern in the United States. Circulation 2016;134:895–6.10.1161/CIRCULATIONAHA.116.024839CrossRefGoogle ScholarPubMed
Lee-Felker, SA, Thomas, M, Felker, ER, et al. Value of cardiac MRI for evaluation of chronic Chagas disease cardiomyopathy. Clin Radiol 2016;71:618.e1–7.10.1016/j.crad.2016.02.015CrossRefGoogle ScholarPubMed
Lewis, MD, Kelly, JM. Putting infection dynamics at the heart of Chagas disease. Trends Parasitol 2016 epub ahead of print.10.1016/j.pt.2016.08.009CrossRefGoogle Scholar
Lorga Filho, AM, Azmus, AD, Soeiro, AM, et al. Brazilian guidelines on platelet antiaggregants and anticoagulants in cardiology. Arq Bras Cardiol 2013;10 (Suppl 3): 1–95.10.5935/abc.2013S009CrossRefGoogle Scholar
Mady, C, Cardoso, RHA, Barretto, AC et al. Survival and predictors of survival in patients with congestive heart failure due to Chagas’ cardiomyopathy. Circulation 1994;90:3098–102.10.1161/01.CIR.90.6.3098CrossRefGoogle ScholarPubMed
Marcolino, MS, Palhares, DM, Ferreira, LR, et al. Electrocardiogram and Chagas disease: A large population database of primary care patients. Glob Heart 2015;10:167–72.10.1016/j.gheart.2015.07.001CrossRefGoogle ScholarPubMed
Martí-Carvajal, AJ, Kwong, JS. Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy. Cochrane Database Syst Rev 2016;7:CD009077Google ScholarPubMed
Massaro, AR, Dutra, AP, Almeida, DR, et al. Transcranial Doppler assessment of cerebral blood flow: Effect of cardiac transplantation. Neurology 2006;66:124–6.10.1212/01.wnl.0000191397.57244.91CrossRefGoogle ScholarPubMed
Miles, MA, Feliciangeli, MD, de Arias, AR. American trypanosomiasis (Chagas’ disease) and the role of molecular epidemiology in guiding control strategies. BMJ 2003;326:1444–8.10.1136/bmj.326.7404.1444CrossRefGoogle ScholarPubMed
Montanaro, VV, da Silva, CM, de Viana Santos, CV, et al. Ischemic stroke classification and risk of enosis in patients with Chagas disease. J Neurol 2016; 263:2411–15.10.1007/s00415-016-8275-0CrossRefGoogle Scholar
Morel, CM. Chagas disease, from discovery to control – and beyond: History, myths and lessons to take home. Mem Inst Oswaldo Cruz 1999;94 Suppl 1:3–16.10.1590/S0074-02761999000700002CrossRefGoogle ScholarPubMed
Morillo, CA, Marin-Neto, JA, Avezum, A, et al. Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy. N Engl J Med 2015;373(14):1295–306.10.1056/NEJMoa1507574CrossRefGoogle ScholarPubMed
Nunes, MC, Barbosa, MM, Ribeiro, AL, et al. Ischemic cerebrovascular events in patients with Chagas cardiomyopathy: A prospective follow-up study. J Neurol Sci 2009;278:96–101.10.1016/j.jns.2008.12.015CrossRefGoogle ScholarPubMed
Nunes, MC, Dones, W, Morillo, CA, et al. Chagas disease: an overview of clinical and epidemiological aspects. J Am Coll Cardiol 2013;62:767–76.10.1016/j.jacc.2013.05.046CrossRefGoogle ScholarPubMed
Nunes, MC, Kreuser, LJ, Ribeiro, AL, et al. Prevalence and risk factors of embolic cerebrovascular events associated with Chagas heart disease. Glob Heart 2015;10:151–7.10.1016/j.gheart.2015.07.006CrossRefGoogle ScholarPubMed
Oliveira-Filho, J, Viana, LC, Vieira de Melo, RM et al. Chagas disease is an independent risk factor for stroke: Baseline characteristics of Chagas disease cohort. Stroke 2005;36:2015–17.10.1161/01.STR.0000177866.13451.e4CrossRefGoogle Scholar
Oliveira-Filho, J, Vieira-de-Melo, RM, Reis, PS, et al. Chagas disease is independently associated with brain atrophy. J Neurol 2009;256:1363–5.10.1007/s00415-009-5105-7CrossRefGoogle ScholarPubMed
Paixão, LC, Ribeiro, AL, Valacio, RA, et al. Chagas disease: Independent risk factor for stroke. Stroke 2009;40:3691–4.10.1161/STROKEAHA.109.560854CrossRefGoogle ScholarPubMed
Pazin-Filho, A, Romano, MM, Almeida-Filho, OC, et al. Minor segmental wall motion abnormalities detected in patients with Chagas’ disease have adverse prognostic implications. Braz J Med Biol Res 2006;39:483–7.10.1590/S0100-879X2006000400008CrossRefGoogle ScholarPubMed
Peix, A, Garcia, R, Sánchez, J, et al. Myocardial perfusion imaging and cardiac involvement in the inderminate phase of Chagas disease. Arq Bras Cardiol 2013;100:114–17.10.5935/abc.20130023CrossRefGoogle Scholar
Pirard, M, Iihoshi, N, Boelaert, M, et al. The validity of serologic test for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region. Transfusion 2005;45:554–61.10.1111/j.0041-1132.2005.04214.xCrossRefGoogle Scholar
Pitella, JE. Ischemic cerebral changes in the chronic chagasic cardiopathy. Arq Neuropsiquiatr 1984;42:105–15.10.1590/S0004-282X1984000200002CrossRefGoogle ScholarPubMed
Prata, A. Evolution of the clinical and epidemiological knowledge about Chagas disease 90 years after its discovery. Mem Inst Oswaldo Cruz 1999;94: Suppl 1:81–8.10.1590/S0074-02761999000700008CrossRefGoogle ScholarPubMed
Rassi, A Jr, Rassi, A, Little, WC, et al. Development and validation of a risk score for predicting death in Chagas’ heart disease. N Engl J Med 2006;355:799–808.10.1056/NEJMoa053241CrossRefGoogle ScholarPubMed
Rassi, A Jr, Rassi, A, Marin-Neto, JA. Chagas disease. Lancet 2010;375:1388–402.10.1016/S0140-6736(10)60061-XCrossRefGoogle ScholarPubMed
Rassi, DC, Vieira, ML, Arruda, AL, et al. Echocardiographic parameters and survival in Chagas heart disease with severe systolic dysfunction. Arq Bras Cardiol 2014;102:245–52.Google ScholarPubMed
Regueiro, A, García-Álvarez, A, Sitges, M, et al. Myocardial involvement in Chagas disease: Insights from cardiac magnetic resonance. Int J Cardiol 2013;165:107–12.10.1016/j.ijcard.2011.07.089CrossRefGoogle ScholarPubMed
Requena-Méndez, A, Aldasoro, E, de Lazzari, E, et al. Prevalence of Chagas disease in Latin-American migrants living in Europe: A systematic review and meta-analysis. PLoS Negl Trop Dis 2015. February 13;9:e000354010.1371/journal.pntd.0003540CrossRefGoogle Scholar
Requena-Méndez, A, Moore, DA, Subirà, C, et al. Addressing the neglect: Chagas disease in London, UK. Lancet Glob Health 2016;4:e231–3.10.1016/S2214-109X(16)00047-4CrossRefGoogle ScholarPubMed
Ribeiro, AL, Rocha, MO. Indeterminate form of Chagas disease: Considerations about diagnosis and prognosis. Rev Soc Bras Med Trop 1998;31:301–14.Google Scholar
Rochitte, CE, Oliveira, PF, Andrade, JM, et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas’ disease: A marker of disease severity. J Am Coll Cardiol 2005;46:1553–8.10.1016/j.jacc.2005.06.067CrossRefGoogle ScholarPubMed
Rothhammer, F, Allison, MJ, Núñez, L, et al. Chagas’ disease in pre-Columbian South America. Am J Phys Anthropol 1985;68:495–8.10.1002/ajpa.1330680405CrossRefGoogle ScholarPubMed
Samuel, J, Oliveira, M, Correa de Araújo, RR, et al. Cardiac thrombosis and thromboembolism in chronic Chagas’ heart disease. Am J Cardiol 1983;52:147–51.Google ScholarPubMed
Schmunis, GA, Yadon, ZE. Chagas disease: A Latin American health problem becoming a world health problem. Acta Trop 2010;115:14–21.10.1016/j.actatropica.2009.11.003CrossRefGoogle ScholarPubMed
Sousa, AS, Xavier, SS, de Freitas, FR, et al. Prevention strategies of cardioembolic ischemic stroke in Chagas disease. Arq Bras Cardiol 2008;91:280–4.Google ScholarPubMed
Trabuco, CC, Pereira de Jesus, PA, Bacellar, AS, et al. Successful thrombolysis in cardioembolic stroke from Chagas disease. Neurology 2005;64:170–1.10.1212/01.WNL.0000148720.81701.B6CrossRefGoogle ScholarPubMed
Torreão, JA, Ianni, BM, Mady, C, et al. Myocardial tissue characterization in Chagas’ heart disease by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2015;17:97.10.1186/s12968-015-0200-7CrossRefGoogle ScholarPubMed
Vilas Boas, LG, Bestetti, RB, Otaviano, AP, et al. Outcome of Chagas cardiomyopathy in comparison to ischemic cardiomyopathy. Int J Cardiol 2013;167:486–90.10.1016/j.ijcard.2012.01.033CrossRefGoogle Scholar
Viotti, RJ, Vigliano, C, Laucella, S, et al. Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure. Heart 2004;90:655–60.10.1136/hrt.2003.018960CrossRefGoogle ScholarPubMed
Walsh, JF, Molyneux, DH, Birley, MH. Deforestation: Effects on vector-borne disease. Parasitology 1993;106 (Suppl): S55–75.10.1017/S0031182000086121CrossRefGoogle ScholarPubMed
World Health Organization (WHO). Chagas disease in Latin America: An epidemiological update based on 2010 estimates. Wkly Epidemiol Rec 2015;90:33–43.Google Scholar
Yadon, ZE, Schmunis, GA. Congenital Chagas disease: Estimating the potential risk in the United States. Am J Trop Med Hyg 2009;81:927–33.10.4269/ajtmh.2009.09-0257CrossRefGoogle ScholarPubMed

References

Abuaf, N., Laperche, S., Rajoely, B., et al. 1997. Auto antibodies to phospholipid and to the coagulation proteins in AIDS. Thromb Haemost, 77, 856–61.Google Scholar
Ake, J. A., Erikson, J. C., and Lowry, K. J. 2006. Cerebral aneurysmal arteriopathy associated with HIV infection in an adult. Clin Infect Dis, 43, e46–50.10.1086/506566CrossRefGoogle ScholarPubMed
Allie, S., Stanley, A., Bryer, A., Meiring, M., and Combrinck, M. I. 2015. High levels of von Willebrand factor and low levels of its cleaving protease, ADAMTS13, are associated with stroke in young HIV-infected patients. Int J Stroke, 10, 1294–6.10.1111/ijs.12550CrossRefGoogle ScholarPubMed
Anders, K. H., Guerra, W. F., Tomiyasu, U., Verity, M. A., and Vinters, H. V. 1986. The neuropathology of AIDS: UCLA experience and review. Am J Pathol, 124, 537–58.Google ScholarPubMed
Benjamin, L. A., Corbett, E. L., Connor, M.D., et al. 2016. HIV, antiretroviral treatment, hypertension and stroke in Malawian adults: A case-control study. Neurology, 86, 1–10.10.1212/WNL.0000000000002278CrossRefGoogle ScholarPubMed
Berger, J. R. 2004. AIDS and stroke risk. Lancet Neurol, 3, 206–7.10.1016/S1474-4422(04)00704-5CrossRefGoogle ScholarPubMed
Berger, J. R., Harris, J. O., Gregarios, J., and Norenberg, M. 1990. Cerebrovascular disease in AIDS: A case control study. AIDS, 4, 239–44.10.1097/00002030-199003000-00010CrossRefGoogle ScholarPubMed
Bissuel, F., Berruyer, M., and Causse, X. 1992. Acquired protein S deficiency: Correlation with advanced disease in HIV-1 infected patients. J Acquir Immune Defic Syndr, 5, 484–9.10.1097/00126334-199205000-00009CrossRefGoogle ScholarPubMed
Budka, H. 1989. Human immunodeficiency virus (HIV)-induced disease of the central nervous system: Pathology and implications for pathogenesis. Acta Neuropathol, 77, 225–36.10.1007/BF00687573CrossRefGoogle ScholarPubMed
Budka, H., Costanzi, G., and Cristina, S. 1987. Brain pathology induced by infection with the human immunodeficiency virus (HIV): A histological, immunocytochemical and electron microscopical study of 100 autopsy cases. Acta Neuropathol (Berlin), 75, 185–98.10.1007/BF00687080CrossRefGoogle ScholarPubMed
Burkholder, G. A., Tamhane, A. R., Salinas, J. L., et al. 2012. Underutilization of aspirin for primary prevention of cardiovascular disease among HIV-infected patients. Clinical Infectious Diseases, 55, 11, 1550–7.10.1093/cid/cis752CrossRefGoogle ScholarPubMed
Calabrese, L. H. 1991. Vasculitis and infection with the human immunodeficiency virus. Rheum Dis Clin North Am, 17, 131–47.10.1016/S0889-857X(21)00093-4CrossRefGoogle ScholarPubMed
Casado Naranjo, I., Toledo Santos, J. A., and Antolin Rodriguez, M. A. 1992. Ischemic stroke as the sole manifestation of human immunodeficiency virus infection. Stroke, 23, 117–8.10.1161/str.23.1.117bCrossRefGoogle Scholar
Chetty, R. 2005. Vasculitides associated with HIV infection. J Clin Pathol, 54, 275–8.Google Scholar
Chetty, R., Batitang, S., and Nair, R. 2000. Large artery vasculopathy in HIV positive patients. Another vasculitic enigma. Hum Pathol, 31, 374–9.10.1016/S0046-8177(00)80253-1CrossRefGoogle ScholarPubMed
Choi, A. I., Vittinghoff, E., Deeks, S. G., et al. 2011. Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons. AIDS 25, 1289–98.10.1097/QAD.0b013e328347fa16CrossRefGoogle ScholarPubMed
Chow, F. C., Regan, S., Feske, S., et al. 2012. Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system. J Acquir Immune Defic Syndr, 60(4), 351–8.10.1097/QAI.0b013e31825c7f24CrossRefGoogle Scholar
Cole, J. W., Pinto, A. N., Hebel, J. R., et al. 2004. Acquired immunodeficiency syndrome and the risk of stroke. Stroke, 35, 51–6.10.1161/01.STR.0000105393.57853.11CrossRefGoogle ScholarPubMed
Cruciani, M., Zanichellib, V., Serpellonia, G., et al. 2011. Abacavir use and cardiovascular disease events: A meta-analysis of published and unpublished data. AIDS 25, 1993–2004.10.1097/QAD.0b013e328349c6eeCrossRefGoogle ScholarPubMed
Connor, M. D., Lammie, G. A., Bell, J. A., et al. 2000. Cerebral infarction in adult AIDS patients. Observations from the Edinburgh HIV autopsy cohort. Stroke, 31, 2117–26.10.1161/01.STR.31.9.2117CrossRefGoogle ScholarPubMed
Dubrovsky, T., Curless, R., Scott, G., et al. 1998. Cerebral aneurysmal arteriopathy in childhood AIDS. Neurology, 51, 560–5.10.1212/WNL.51.2.560CrossRefGoogle ScholarPubMed
Engstroom, J. W., Lowenstein, D. H., and Bredesen, D. E. 1989. Cerebral infarction and transient neurological deficits associated with acquired immune deficiency syndrome. AmJ Med, 86, 528–32.10.1016/0002-9343(89)90379-3CrossRefGoogle Scholar
Erbe, M., Rickerts, V., and Bauersachs, R. M. 2003. Acquired protein C and protein S deficiency in HIV infected patients. Clin Appl Thromb Haemost, 9, 325–31.10.1177/107602960300900408CrossRefGoogle ScholarPubMed
Evers, S., Nabavi, D., Ratiman, A., et al. 2003. Ischemic cerebrovascular events in HIV infection, a cohort study. Cerebrovasc Dis, 15, 199–205.10.1159/000068828CrossRefGoogle ScholarPubMed
Freiberg, M. S., Chang, C. H., Kuller, L. H., and Skanderson, M. 2013. HIV Infection and the risk of acute myocardial infarction. JAMA Intern Med, 173, 614–22.10.1001/jamainternmed.2013.3728CrossRefGoogle ScholarPubMed
Friis-Møller, N., Thiébaut, R., Reiss, P., et al. for the DAD study group. 2010. Predicting the risk of cardiovascular disease in HIV-infected patients: The data collection on adverse effects of anti-HIV drugs study. Eur J Cardiovasc Prev Rehabil, 17, 5, 491–501.10.1097/HJR.0b013e328336a150CrossRefGoogle Scholar
Gherardi, R., Belec, L., and Mhin, C. 1993. The spectrum of vasculitis in human immunodeficiency virus-infected patients. Arthritis Rheum, 36, 1164–74.10.1002/art.1780360818CrossRefGoogle ScholarPubMed
Gillams, A. R., Allen, E., Hrieb, K., et al. 1997. Cerebral infarction in patients with AIDS. AJNR Am J Neuroradiol, 18, 1581–5.Google ScholarPubMed
Gisselbrecht, M., Cohen, P., and Lortholary, D. 1998. Human immunodeficiency virus-related vasculitis. Clinical presentation of and therapeutic approach to eight cases. Ann Med Interne (Paris), 149, 398–405.Google ScholarPubMed
Goeijenbier, M., van Wissen, M., van de Weg, C., et al. 2012. Viral infections and mechanisms of thrombosis and bleeding. J Med Virol 84, 1680–96.10.1002/jmv.23354CrossRefGoogle ScholarPubMed
Gutierrez, J. and Ortiz, G. 2011. HIV/AIDS patients with HIV vasculopathy and VZV vasculitis: A case series. Clin Neuroradiol, 21, 145–51.10.1007/s00062-011-0087-0CrossRefGoogle ScholarPubMed
Hanna, D. B., Post, W. S., Deal, J. A., et al. 2015. HIV infection is associated with progression of subclinical carotid atherosclerosis. Clin Infect Dis 61, 640–50.10.1093/cid/civ325CrossRefGoogle ScholarPubMed
Hassell, K. L., Kressin, D. C., Neumann, A., Ellison, R., and Marlar, R. A. 1994. Correlation of antiphospholipid antibodies and protein S deficiency with thrombosis in HIV infected men. Blood Coagul Fibrinolysis, 5, 455–62.Google ScholarPubMed
Ho, D. D., Pomerantz, R. J., and Kaplan, J. C. 1987. Pathogenesis of infection with human immunodeficiency virus. N Engl J Med, 317, 278–86.Google ScholarPubMed
Hoffman, M., Berger, J. R., Nath, A., and Rayens, M. 2000. Cerebrovascular disease in young HIV infected black Africans in the Kwa-Zulu Natal Province of South Africa. J Neurovirol, 6, 229–36.10.3109/13550280009015825CrossRefGoogle Scholar
Hsue, P. Y., Lo, J. C., Franklin, A., et al. 2004. Progression of atherosclerosis as assessed by carotid intima–media thickness in patients with HIV infection. Circulation 109, 1603–8.10.1161/01.CIR.0000124480.32233.8ACrossRefGoogle ScholarPubMed
Joshi, V. V., Pawel, B., Connor, E., et al. 1987. Arteriopathy in children with acquired immune deficiency syndrome. Pediatr Pathol, 7, 261–75.Google ScholarPubMed
Kossorotoff, M., Touzé, E., Godon-Hardy, S., et al. 2006. Cerebral vasculopathy with aneurysm formation in HIV-infected young adults. Neurology, 66, 1121–2.10.1212/01.wnl.0000204188.85402.0cCrossRefGoogle ScholarPubMed
Kumwenda, J. J., Mateyu, G., Kampondeni, S., et al. 2005. Differential diagnosis of stroke in a setting of high HIV prevalence in Blantyre, Malawi. Stroke, 36, 960–4.10.1161/01.STR.0000162585.97216.efCrossRefGoogle Scholar
Kuwe, K., Llena, J. F., and Lyman, W. D. 1991. Human immunodeficiency virus-1 infection of the nervous system: An autopsy study of 268 adult, paediatric and foetal brains. Hum Pathol, 22, 700–10.Google Scholar
Lang, W., Miklossy, J., Deruaz, J. P., et al. 1989. Neuropathology of the acquired immune deficiency syndrome (AIDS): A report of 135 consecutive autopsy cases from Switzerland. Acta Neuropathol (Berlin), 77, 379–90.10.1007/BF00687372CrossRefGoogle ScholarPubMed
Libman, B. S., Quismorio, F. P. Jr., and Stimmler, M. M. 1995. Polyarteritis nodosa like vasculitis in human deficiency virus infection. J Rheumatol, 22, 351–5.Google Scholar
Maniker, A. L. and Hunt, C. D. 1996. Cerebral aneurysm in the HIV patient: A report of six cases. Surg Neurol, 46, 49–54.10.1016/0090-3019(96)00030-4CrossRefGoogle Scholar
Marcus, J. L., Leyden, W. A., Chaob, C. R., et al. 2014. HIV infection and incidence of ischemic stroke. AIDS, 28, 1911–1919.10.1097/QAD.0000000000000352CrossRefGoogle ScholarPubMed
Martin, C. M., Matlow, A. G., Chew, E., Sutton, D., and Pruzanski, W. 1989. Hyperviscosity syndrome in a patient with acquired immunodeficiency syndrome. Arch Intern Med, 149, 1435–6.10.1001/archinte.1989.00390060143033CrossRefGoogle Scholar
Martinez-Longoria, C. A., Morales-Aguirre, J. J., Villalobos-Acosta, C. P., Gomez-Barreto, D., and Cashat-Cruz, M. 2004. Occurrence of intracerebral aneurysm in an HIV-infected child: A case report. Pediatr Neurol, 31, 130–2.10.1016/j.pediatrneurol.2004.02.008CrossRefGoogle Scholar
Mazzoni, P., Chiriboga, C. A., Millar, W. S., and Rogers, A. 2000. Intracerebral aneurysms in human immunodeficiency virus infection: Case report and literature review. Pediatr Neurol, 23, 252–5.10.1016/S0887-8994(00)00179-XCrossRefGoogle Scholar
Mizusawa, H., Hirano, A., Llena, J. F., and Shintaku, M. 1988. Cerebrovascular lesions in acquired immune deficiency syndrome (AIDS). Acta Neuropathol, 76, 451–7.10.1007/BF00686383CrossRefGoogle ScholarPubMed
Mochan, A., Modi, M., and Modi, G. 2003. Stroke in black South African HIV positive patients, a prospective analysis. Stroke, 34, 10–15.10.1161/01.STR.0000043821.35051.FACrossRefGoogle ScholarPubMed
Mochan, A., Modi, M., and Modi, G. 2005. Protein S deficiency in HIV associated ischemic stroke: An epiphenomenon of HIV infection. J Neurol Neurosurg Psychiatry, 76, 1455–6.10.1136/jnnp.2004.059733CrossRefGoogle Scholar
Nagel, M. A., Cohrs, R. J., Mahalingam, R., et al. 2008. The varicella zoster virus vasculopathies: Clinical, CSF, imaging and virologic features. Neurology, 70, 853.10.1212/01.wnl.0000304747.38502.e8CrossRefGoogle ScholarPubMed
Nair, R., Chetty, R., Woolgar, J., Naidoo, N. G., and Robbs, J. V. 2001. Spontaneous arteriovenous fistula resulting from HIV arteritis. J Vasc Surg, 33, 186–7.10.1067/mva.2001.108633CrossRefGoogle ScholarPubMed
Nunes, M. L., Pinho, A. P., and Sfoggia, A. 2001. Cerebral aneurysmal dilatation in an infant with perinatally acquired HIV infection and HSV encephalitis. Arq Neuropsiquiatr, 59, 830.10.1590/S0004-282X2001000100024CrossRefGoogle Scholar
Ovbiagele, B. and Nath, A. 2011. Increasing incidence of ischemic stroke in patients with HIV infection. Neurology, 76, 444.10.1212/WNL.0b013e31820a0cfcCrossRefGoogle ScholarPubMed
Patel, V. B., Sacoor, Z., Francis, P., et al. 2005. Ischemic stroke in young HIV positive patients in Kwa-Zulu Natal, South Africa. Neurology, 65, 759–61.10.1212/01.wnl.0000174434.00402.b5CrossRefGoogle Scholar
Patsalides, A. D., Wood, L. V., Atac, G. K., et al. 2002. Cerebrovascular disease in HIV-infected pediatric patients. AJR Am J Roentgenol, 179, 999–1003.10.2214/ajr.179.4.1790999CrossRefGoogle ScholarPubMed
Petito, C. K., Cho, E. S., Lemann, W., Naria, B. A., and Price, R. W. 1986. Neuropathology of acquired immunodeficiency syndrome (AIDS): An autopsy review. J Neuropathol Exp Neurol, 45, 635–46.10.1097/00005072-198611000-00003CrossRefGoogle ScholarPubMed
Pinto, A. N. 1996. AIDS and cerebrovascular disease. Stroke, 27, 538–43.10.1161/01.STR.27.3.538CrossRefGoogle ScholarPubMed
Qureshi, A. I. 2005. HIV infection and stroke: If not protein S deficiency then what explains the relationship. J Neurol Neurosurg Psychiatry, 76, 1331.10.1136/jnnp.2005.072017CrossRefGoogle Scholar
Qureshi, A. I., Janssen, R. S., Karon, J. M., et al. 1997. Human immunodeficiency virus infection and stroke in young patients. Arch Neurol, 54, 1150–3.10.1001/archneur.1997.00550210078016CrossRefGoogle ScholarPubMed
Rabinstein, A. A. 2003. Stroke in HIV-infected patients: A clinical perspective. Cerebrovasc Dis, 15, 37–44.10.1159/000067120CrossRefGoogle ScholarPubMed
Rhodes, R. H. 1987. Histopathology of the central nervous system in the acquired immunodeficiency syndrome. Hum Pathol, 18, 636–43.10.1016/S0046-8177(87)80365-9CrossRefGoogle ScholarPubMed
Rhodes, R. H. and Ward, J. M. 1991. AIDS meningoencephalomyelitis: Pathogenesis and changing neuropathological findings. Pathol Annu, 26, 247–76.Google Scholar
Rubbert, A., Bock, E., Schwab, J., et al. 1994. Anticardiolipin antibodies in HIV infection: Association with cerebral perfusion defects as detected by 99 mTc–HMPAO SPECT. Clin Exp Immunol, 98, 361–8.Google Scholar
Shahbaz, S., Manicardi, M., Guaraldi, G., and Raggi, P. 2015. Cardiovascular disease in human immunodeficiency virus infected patients: A true or perceived risk? World J Cardiol 7, 633–44.10.4330/wjc.v7.i10.633CrossRefGoogle ScholarPubMed
Sico, J. J., Chang, C. C., So-Armah, K., et al. 2015. HIV status and the risk of ischemic stroke among men. Neurology, 84, 1933–40.10.1212/WNL.0000000000001560CrossRefGoogle ScholarPubMed
Sklar, P., and Masur, H. 2003. HIV infection and cardiovascular disease: Is there really a link? N Engl J Med, 349, 2065–7.10.1056/NEJMe038158CrossRefGoogle ScholarPubMed
Sorice, M., Griggi, T., and Arceria, P. 1994. Protein S and HIV infection. The role of anticardiolysis and antiprotein S. Thromb Res, 73, 65–175.10.1016/0049-3848(94)90095-7CrossRefGoogle Scholar
Stahl, C. P., Wideman, C. S., and Spira, T. J. 1993. Protein S deficiency in men with long term human immunodeficiency virus infection. Blood, 81, 1801–7.10.1182/blood.V81.7.1801.1801CrossRefGoogle ScholarPubMed
Statistics, SA. 2014. Mid-year population estimates 2014. See www.statssa.gov.za/publications/P0302/P03022014.pdf.Google Scholar
Sugerman, R. W., Church, J. A., and Goldsmith, J. C. 1996. Acquired protein S deficiency in children infected with human immunodeficiency virus. Pediatr Infect Dis J, 15, 106–11.10.1097/00006454-199602000-00003CrossRefGoogle ScholarPubMed
Tipping, B., de Villiers, L., Candy, S., and Wainwright, H. 2006. Stroke caused by human immunodeficiency virus-associated intracranial large-vessel aneurysmal vasculopathy. Arch Neurol, 63, 1640–2.10.1001/archneur.63.11.1640CrossRefGoogle ScholarPubMed
Tipping, B., de Villiers, L., Wainright, H., Candy, S., and Bryer, A. 2007. Stroke in human immunodeficiency virus infections. J Neurol, Neurosurg, and Psychiatr, 78, 1320–4.10.1136/jnnp.2007.116103CrossRefGoogle Scholar
Valeriano-Marcet, J., Ravichandran, L., and Kerr, L. D. 1990. HIV associated systemic necrotising vasculitis. J Rheumatol, 17, 1091–3.Google Scholar
Van den Dries, L. W., Gruters, R. A., Hovels-van der Borden, S. B., et al. 2015. Von Willebrand factor is elevated in HIV patients with a history of thrombosis. Front Microbiol, 6, 180.10.3389/fmicb.2015.00180CrossRefGoogle ScholarPubMed
Walker, R. W., Jusabani, A., Aris, E., et al. 2013. Stroke risk factors in an incident population in urban and rural Tanzania: A prospective, community-based, case control study. Lancet Glob Health, 1, e282–e288.10.1016/S2214-109X(13)70068-8CrossRefGoogle Scholar
Worm, S. W., Sabin, C., Weber, R., et al. for the D:A:D Study Group. 2010. Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. J Infect Dis, 201, 318–30.10.1086/649897CrossRefGoogle ScholarPubMed
Young, J., Xiao, Y., Moodie, E. M., et al. 2015. Effect of cumulating exposure to abacavir on the risk of cardiovascular disease events in patients from the Swiss HIV cohort study. J Acquir Immune Defic Syndr, 69, 413–21.10.1097/QAI.0000000000000662CrossRefGoogle ScholarPubMed

References

Ahmadi, J, Tung, H, Giannotta, SL, Destian, S. Monitoring of infectious intracranial aneurysms by sequential computed tomographic/magnetic resonance imaging studies. Neurosurgery, 1993, 32:45–50.10.1227/00006123-199301000-00007CrossRefGoogle ScholarPubMed
Asaithambi, G, Adil, MM, Qureshi, AI. Thrombolysis for ischemic stroke associated with infective endocarditis results from the nationwide inpatient sample. Stroke, 2013, 44:2917–19.10.1161/STROKEAHA.113.001602CrossRefGoogle ScholarPubMed
Aziz, F, Perwaiz, S, Penupolu, S, et al. Intracranial hemorrhage in infective endocarditis: A case report. J Thorac Dis, 2011, 3:134–7.Google ScholarPubMed
Baddley, JW, Benjamin, DK, Patel, M, et al. Candida infective endocarditis. Eur J Clin Microbiol Infect Dis, 2008, 27:519–29.10.1007/s10096-008-0466-xCrossRefGoogle ScholarPubMed
Baddour, LM, Wilson, LM Infections of prosthetic valves and other cardiovascular devices: Intravascular devices. Mandel, Douglas and Bennett’s Principles and Practice and Infectious Diseases, 5th edn., eds. Mandell, GL, Bennett, JE, Dolin, R. Philadelphia, PA: Elsevier, 2005, 1022–1044.Google Scholar
Baddour, LM, Wilson, WR, Bayer, AS Infective endocarditis in adults: Diagnosis, antimicrobial therapy and management of complications. AHA scientific statement. Circulation, 2015, 132:1435–86.10.1161/CIR.0000000000000296CrossRefGoogle Scholar
Barsic, B, Dickerman, S, Krajinovic, V, et al. Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke. Clin Infect Dis, 2013, 56:209–17.10.1093/cid/cis878CrossRefGoogle ScholarPubMed
Bashore, TM, Cabell, C, Fowler, V. Update on infective endocarditis. Curr Probl Cardiol, 2006, 31:274–352.10.1016/j.cpcardiol.2005.12.001CrossRefGoogle ScholarPubMed
Bringham, WL Treatment of mycotic intracranial aneurysms. J Neurosurg, 1977, 46:428–37.Google Scholar
Castillo, JC, Anguita, MP, Ramirez, A, et al. Long term outcome of infective endocarditis in patients who were not drug addicts: A 10 year study. Heart, 2000, 83:525–30.10.1136/heart.83.5.525CrossRefGoogle Scholar
Champey, J, Pavese, P, Bouvaist, H, et al. Value of brain MRI in infective endocarditis: A narrative literature review. Eur J Clin Microbiol Infect Dis, 2016, 35:159–168.10.1007/s10096-015-2523-6CrossRefGoogle ScholarPubMed
Chan, KL, Dumesnil, JG, Cujec, B, et al. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol, 2003, 42:775–80.10.1016/S0735-1097(03)00829-5CrossRefGoogle ScholarPubMed
Corr, P, Wright, M, Handler, LC Endocarditis-related cerebral aneurysms: Radiologic changes with treatment. Neurosurgery, 1993, 32:45–9.Google Scholar
Dickerman, SA, Abrutyn, E, Barsic, B, et al. The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: An analysis from the ICE Prospective Cohort Study (ICE–PCS). Am Heart J, 2007, 154:1086–94.10.1016/j.ahj.2007.07.023CrossRefGoogle ScholarPubMed
Ducruet, AF, Hickman, ZL, Zacharia, BE, et al. Intracranial infectious aneurysms: A comprehensive review. Neurosurg Rev, 2010, 33:37–46.10.1007/s10143-009-0233-1CrossRefGoogle ScholarPubMed
Frazee, JG, Cahan, LD, Winter, J. Bacterial intracranial aneurysms. J Neurosurg, 1980, 53:633–41.10.3171/jns.1980.53.5.0633CrossRefGoogle ScholarPubMed
García-Cabrera, E, Fernández-Hidalgo, N, Almirante, B et al. Neurological complications of infective endocarditis: Risk factors, outcome, and impact of cardiac surgery – a multicenter observational study. Circulation, 2013, 127:2272–84.10.1161/CIRCULATIONAHA.112.000813CrossRefGoogle ScholarPubMed
Hart, RG, Foster, JW, Luther, MF, Kanter, MC Stroke in infective endocarditis. Stroke, 1990, 21:695–700.10.1161/01.STR.21.5.695CrossRefGoogle ScholarPubMed
Hart, RG, Kagan-Hallet, K, Joerns, S. Mechanism of intracranial hemorrhage in infective endocarditis. Stroke, 1987, 18:1046–56.10.1161/01.STR.18.6.1048CrossRefGoogle ScholarPubMed
Heiro, M, Nikoskelainen, J, Engblom, E, et al. Neurologic manifestation of infective endocarditis. A 17-year experience in a teaching hospital in Finland. Arch Intern Med, 2000, 160:2781–7.10.1001/archinte.160.18.2781CrossRefGoogle Scholar
Hess, A, Klein, I, Iung, B et al. 44 Brain MRI findings in neurologically asymptomatic patients with infective endocarditis. Am J Neuroradiol, 2013, 34:1579–84.10.3174/ajnr.A3582CrossRefGoogle ScholarPubMed
Hill, EE, Herijgers, P, Claus, P, et al. Infective endocarditis: changing epidemiology and predictors of 6 month mortality: A prospective cohort study. Eur Heart J, 2007, 28:196.10.1093/eurheartj/ehl427CrossRefGoogle ScholarPubMed
Hui, FK, Bain, M, Obuchowski, NA, et al. Mycotic aneurysm detection rates with cerebral angiography in patients with infective endocarditis. J NeuroIntervent Surg, 2015, 7:449–52.10.1136/neurintsurg-2014-011124CrossRefGoogle ScholarPubMed
Jeong-Min, K, Ji-Su, J, Yong-Won, K. Forced arterial suction thrombectomy of septic embolic middle cerebral artery occlusion due to infective endocarditis: An illustrative case and review of the literature. Neurointervention, 2014, 9:101–5.Google Scholar
Karchmer, AW. Infective endocarditis. In Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, 7th edn. WB Saunders Co, 2005, pp. 1633–58.Google Scholar
Klein, I, Iung, B, Labreuche, J, et al. Cerebral microbleeds are frequent in infective endocarditis: A case control study. Stroke, 2009, 40:3461–5.10.1161/STROKEAHA.109.562546CrossRefGoogle ScholarPubMed
Lee, WK, Mossop, PJ, Little, AF, et al. Infected (mycotic) aneurysms: Spectrum of imaging appearances and management. Radiographics, 2008, 28:1853–68.10.1148/rg.287085054CrossRefGoogle ScholarPubMed
Merkler, AE, Chu, SY, Lerario, MP, et al. Temporal relationship between infective endocarditis and stroke. Neurology, 2015, 85:512–16.10.1212/WNL.0000000000001835CrossRefGoogle ScholarPubMed
Molinari, GF, Smith, L, Goldstein, MN, Satran, R. Pathogenesis of cerebral mycotic aneurysms. Neurology, 1973, 23:325–32.10.1212/WNL.23.4.325CrossRefGoogle ScholarPubMed
Moreillon, P, Que, YA, Bayer, AS Pathogenesis of streptococcal and staphylococcal endocarditis. Infect Dis Clin North Am, 2002, 16:297–318.10.1016/S0891-5520(01)00009-5CrossRefGoogle ScholarPubMed
Moreillon, P, Que, YA Infective endocarditis. Lancet, 2004, 363:139–49.10.1016/S0140-6736(03)15266-XCrossRefGoogle ScholarPubMed
Ohira, S, Doi, K, Kawajiri, H, et al. Prediction of early postoperative cerebral hemorrhage in infective endocarditis patients using magnetic resonance imaging. Gen Thorac Cardiovasc Surg, 2014, 62:608–13.10.1007/s11748-014-0416-8CrossRefGoogle ScholarPubMed
Peters, PJ, Harrison, T, Lennox, JL A dangerous dilemma: Management of infectious intracranial aneurysms complicating endocarditis. Lancet Infect Dis, 2006, 6:742–48.10.1016/S1473-3099(06)70631-4CrossRefGoogle ScholarPubMed
Rizzi, M, Ravasio, V, Carobbio, A, et al. Predicting the occurrence of embolic events: An analysis of 1456 episodes of infective endocarditis from the Italian Study on Endocarditis (SEI). BMC Infect Dis, 2014, 14:230.10.1186/1471-2334-14-230CrossRefGoogle Scholar
Ruttmann, E, Willeit, J, Ulmer, H, et al. Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke, 2006, 37:2094.10.1161/01.STR.0000229894.28591.3fCrossRefGoogle ScholarPubMed
Salgado, AV, Furlan, AJ, Keys, TF, et al. Neurologic complications of endocarditis: A 12-year experience. Neurology, 1989, 39:173–8.10.1212/WNL.39.2.173CrossRefGoogle ScholarPubMed
Singhal, AB, Topcuoglu, MA, Buonanno, FS. Original contributions: Acute ischemic stroke patterns in infective and non bacterial thrombotic endocarditis: A diffusion-weighted magnetic resonance imaging study. Stroke, 2002, 33:1267–73.10.1161/01.STR.0000015029.91577.36CrossRefGoogle Scholar
Snygg-Martin, U, Gustafsson, L, Rosengren, L. Cerebrovascular complications in patients with left-sided infective endocarditis are common: A prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis, 2008, 47:23.10.1086/588663CrossRefGoogle Scholar
Steckelberg, JM, Murphy, JG, Ballard, D, et al. Emboli in infective endocarditis: The prognostic value of echocardiography. Ann Intern Med, 1991, 114:635–40.10.7326/0003-4819-114-8-635CrossRefGoogle ScholarPubMed
Tornos, MP, Permanyer-Miralda, G, Olona, M, et al. Long-term complications of native valve infective endocarditis in non-addicts. A 15-year follow-up study. Ann Intern Med, 1992, 117:567.10.7326/0003-4819-117-7-567CrossRefGoogle ScholarPubMed
Weinstein, LW, Brusch, JL. Infective Endocarditis. New York, NY: Oxford University Press, 1996.Google Scholar
Whitlock, RP, Sun, JC, Fremes, SE, et al. Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th edn: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012, (2 Suppl):e576S.10.1378/chest.11-2305CrossRefGoogle Scholar
Zanaty, M, Chalouhi, N, Starke, RM, et al. Endovascular treatment of cerebral mycotic aneurysm: A review of the literature and single center experience. BioMed Res Int, 2013, 151643.Google Scholar

References

Amlie-Lefond, C., Kleinschmidt-DeMasters, B. K., Mahalingam, R., Davis, L. E., and Gilden, D. H. 1995. The vasculopathy of varicella-zoster virus encephalitis. Ann Neurol, 37, 784–90.10.1002/ana.410370612CrossRefGoogle ScholarPubMed
Askalan, R., Laughlin, S., Mayank, S., et al. 2001. Chickenpox and stroke in childhood: A study of frequency and causation. Stroke, 32, 1257–62.10.1161/01.STR.32.6.1257CrossRefGoogle ScholarPubMed
Aurelius, E., Johansson, B., Skoldenberg, B., Staland, A., and Forsgren, M. 1991. Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid. Lancet, 337, 189–92.10.1016/0140-6736(91)92155-UCrossRefGoogle ScholarPubMed
Baudouin, E., and Lantuejoul, P. 1919. Les troublecas moteurs dans le zona. Gazette des Hopitaux.Google Scholar
Braun, K. P., Bulder, M. M., Chabrier, S., et al. 2009. The course and outcome of unilateral intracranial arteriopathy in 79 children with ischaemic stroke. Brain, 132, 544–57.Google ScholarPubMed
Breuer, J., Pacou, M., Gauthier, A., and Brown, M. M. 2014. Herpes zoster as a risk factor for stroke and TIA: A retrospective cohort study in the UK. Neurology, 82, 206–12.10.1212/WNL.0000000000000038CrossRefGoogle Scholar
Cheng-Ching, E., Jones, S., Hui, F. K., et al. 2015. High-resolution MRI vessel wall imaging in varicella zoster virus vasculopathy. J Neurol Sci, 351, 168–73.10.1016/j.jns.2015.02.017CrossRefGoogle ScholarPubMed
Ciccone, S., Faggioli, R., Calzolari, F., et al. 2010. Stroke after varicella-zoster infection: Report of a case and review of the literature. Pediatr Infect Dis J, 29, 864–7.10.1097/INF.0b013e3181ddefb6CrossRefGoogle ScholarPubMed
Devinsky, O., Cho, E. S., Petito, C. K., and Price, R. W. 1991. Herpes zoster myelitis. Brain, 114, 1181–96.10.1093/brain/114.3.1181CrossRefGoogle ScholarPubMed
Ferry, G., Lonchampt, M., Pennel, L., et al. 1997. Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury. FEBS Lett, 402, 111–5.10.1016/S0014-5793(96)01508-6CrossRefGoogle Scholar
Frid, M.G., Brunetti, J. A., Burke, D. L., et al. 2006. Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. Am J Pathol, 168, 659–69.10.2353/ajpath.2006.050599CrossRefGoogle ScholarPubMed
Fukumoto, S., Kinjo, M., Hokamura, K., and Tanaka, K. 1986. Subarachnoid hemorrhage and granulomatous angiitis of the basilar artery: Demonstration of the varicella-zoster-virus in the basilar artery lesions. Stroke, 17, 1024–8.10.1161/01.STR.17.5.1024CrossRefGoogle ScholarPubMed
Gilden, D. H., Beinlich, B. R., Rubinstien, E. M., et al. 1994. Varicella-zoster virus myelitis: An expanding spectrum. Neurology, 44, 1818–23.10.1212/WNL.44.10.1818CrossRefGoogle ScholarPubMed
Gilden, D. H., Kleinschmidt-DeMasters, B. K., Wellish, M., et al. 1996. Varicella zoster virus, a cause of waxing and waning vasculitis: New England Journal of Medicine case 5–1995 revisited. Neurology, 47, 1441–6.10.1212/WNL.47.6.1441CrossRefGoogle ScholarPubMed
Gilden, D., White, T., Khmeleva, N., et al. 2015. Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis. Neurology, 84, 1948–55.10.1212/WNL.0000000000001409CrossRefGoogle ScholarPubMed
Gilden, D., White, T., Khmeleva, N., Boyer, P. J., and Nagel, M. A. 2016. VZV in biopsy-positive and -negative giant cell arteritis: Analysis of 100+ temporal arteries. Neurol Neuroimmunol Neuroinflamm, 3, e16.10.1212/NXI.0000000000000216CrossRefGoogle ScholarPubMed
Hartney, T., Birari, R., Venkataraman, S., et al. 2011. Xanthine oxidase-derived ROS upregulate Egr-a via ERK ½ in PA smooth muscle cells; model to test impact of extracellular ROS in chronic hypoxia. PLoS One, 6, doi: 10.1371/journal/pone.0027531.CrossRefGoogle Scholar
Haug, A., Mahalingam, R., Cohrs, R. J., et al. 2010. Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system: Case report and review of the literature. J Neurol Sci, 292, 85–8.10.1016/j.jns.2010.01.019CrossRefGoogle ScholarPubMed
Heymann, A. D., Chodick, G., Karpati, T., et al. 2008. Diabetes as a risk factor for herpes zoster infection: Results of a population-based study in Israel. Infection, 36, 226–30.10.1007/s15010-007-6347-xCrossRefGoogle ScholarPubMed
Hsieh, C. C., Yen, M. H., Yen, C. H., and Lau, Y. T. 2001. Oxidized low density lipoprotein induces apoptosis via generation of reactive oxygen species in vascular smooth muscle cells. Cardiovasc Res, 49, 135–45.10.1016/S0008-6363(00)00218-2CrossRefGoogle ScholarPubMed
Itoh, Y., and Nagase, H. 1995. Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase. J Biol Chem, 270, 16518–21.10.1074/jbc.270.28.16518CrossRefGoogle Scholar
Kang, J. H., Ho, J. D., Chen, Y. H., and Lin, H. C. 2009. Increased risk of stroke after a herpes zoster attack: A population-based follow-up study. Stroke, 40, 3443–8.10.1161/STROKEAHA.109.562017CrossRefGoogle ScholarPubMed
Langan, S. M., Minassian, C., Smeeth, L., and Thomas, S. L. 2014. Risk of stroke following herpes zoster: A self-controlled case-series study. Clin Infect Dis, 58, 1497–503.10.1093/cid/ciu098CrossRefGoogle ScholarPubMed
Lanthier, S., Armstrong, D., Domi, T., and deVeber, G. 2005. Post-varicella arteriopathy of childhood: Natural history of vascular stenosis. Neurology, 64, 660–3.10.1212/01.WNL.0000151851.66154.27CrossRefGoogle ScholarPubMed
Li, J., Li, W., Su, J., et al. 2003. Hydrogen peroxide induces apoptosis in cerebral vascular smooth muscle cells: Possible relation to neurodegenerative diseases and strokes. Brain Res Bull, 62, 101–6.10.1016/j.brainresbull.2003.08.011CrossRefGoogle ScholarPubMed
Liberman, A. L., Nagel, M. A., Hurley, M. C., et al. 2014. Rapid development of 9 cerebral aneurysms in varicella-zoster virus vasculopathy. Neurology, 82, 2139–41.10.1212/WNL.0000000000000503CrossRefGoogle ScholarPubMed
Lin, H. C., Chien, C. W., and Ho, J. D. 2010. Herpes zoster ophthalmicus and the risk of stroke: A population-based follow-up study. Neurology, 74, 792–7.10.1212/WNL.0b013e3181d31e5cCrossRefGoogle ScholarPubMed
Mathias, M., Nagel, M.A., Khmeleva, N., et al. 2013. VZV multifocal vasculopathy with ischemic optic neuropathy, acute retinal necrosis and temporal artery infection in the absence of zoster rash. J Neurol Sci, 325, 180–2.10.1016/j.jns.2012.12.021CrossRefGoogle ScholarPubMed
Minassian, C., Thomas, S. L., Smeeth, L., et al. 2015. Acute cardiovascular events after herpes zoster: A self-controlled case series analysis in vaccinated and unvaccinated older residents of the United States. PLoS Med, 12, e1001919.10.1371/journal.pmed.1001919CrossRefGoogle ScholarPubMed
Miravet, E., Danchaivijitr, N., Basu, H., Saunders, D. E., and Ganesan, V. 2007. Clinical and radiological features of childhood cerebral infarction following varicella zoster virus infection. Dev Med Child Neurol, 49, 417–22.10.1111/j.1469-8749.2007.00417.xCrossRefGoogle ScholarPubMed
Nagel, M. A., Forghani, B., Mahalingam, R., et al. 2007. The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology, 68, 1069–73.10.1212/01.wnl.0000258549.13334.16CrossRefGoogle ScholarPubMed
Nagel, M. A., Cohrs, R. J., Mahalingam, R., et al. 2008. The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology, 70, 853–60.10.1212/01.wnl.0000304747.38502.e8CrossRefGoogle ScholarPubMed
Nagel, M. A., Traktinskiy, I., Azarkh, Y., et al. 2011. Varicella zoster virus vasculopathy: Analysis of virus-infected arteries. Neurology, 77, 364–70.10.1212/WNL.0b013e3182267bfaCrossRefGoogle ScholarPubMed
Nagel, M. A., Traktinskiy, I., Choe, A., Rempel, A., and Gilden, D. 2012. Varicella-zoster virus expression in the cerebral arteries of diabetic subjects. Arch Neurol, 69, 142–4.10.1001/archneur.69.1.142CrossRefGoogle ScholarPubMed
Nagel, M. A., Bennett, J. L., Khmeleva, N., et al. 2013a. Multifocal VZV vasculopathy with temporal artery infection mimics giant cell arteritis. Neurology, 80, 2017–21.10.1212/WNL.0b013e318294b477CrossRefGoogle ScholarPubMed
Nagel, M. A., Choe, A., Khmeleva, N., et al. 2013b. Search for varicella zoster virus and herpes simplex virus-1 in normal human cerebral arteries. J Neurovirol, 19, 181–5.10.1007/s13365-013-0155-0CrossRefGoogle ScholarPubMed
Nagel, M.A., Khmeleva, N., Boyer, P.J., Choe, A., Bert, R., and Gilden, D. 2013c. Varicella zoster virus in the temporal artery of a patient with giant cell arteritis. J Neurol Sci, 335, 228–30.10.1016/j.jns.2013.09.034CrossRefGoogle ScholarPubMed
Nagel, M. A., Russman, A. N., Feit, H., et al. 2013d. VZV ischemic optic neuropathy and subclinical temporal artery infection without rash. Neurology, 80, 220–2.10.1212/WNL.0b013e31827b92d1CrossRefGoogle ScholarPubMed
Nagel, M. A., Traktinskiy, I., Stenmark, K. R., et al. 2013e. Varicella-zoster virus vasculopathy: immune characteristics of virus-infected arteries. Neurology, 80, 62–8.10.1212/WNL.0b013e31827b1ab9CrossRefGoogle ScholarPubMed
Nagel, M. A., Khmeleva, N., Choe, A., Gutierrez, J., and Gilden, D. 2014. Varicella zoster virus (VZV) in cerebral arteries of subjects at high risk for VZV reactivation. J Neurol Sci, 339, 32–4.10.1016/j.jns.2014.01.044CrossRefGoogle ScholarPubMed
Nagel, M. A., White, T., Khmeleva, N., et al. 2015. Analysis of varicella-zoster virus in temporal arteries biopsy positive and negative for giant cell arteritis. JAMA Neurol, 72, 1281–7.10.1001/jamaneurol.2015.2101CrossRefGoogle ScholarPubMed
Okada, Y., and Nakanishi, I. 1989. Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 (‘gelatinase’) by human neutrophil elastase and cathepsin G. FEBS Lett, 249, 353–6.10.1016/0014-5793(89)80657-XCrossRefGoogle ScholarPubMed
Sabry, A., Hauk, P. J., Jing, H., et al. 2014. Vaccine strain varicella-zoster virus-induced central nervous system vasculopathy as the presenting feature of DOCK8 deficiency. J Allergy Clin Immunol, 133, 1225–7.10.1016/j.jaci.2013.11.031CrossRefGoogle Scholar
Salazar, R., Russman, A. N., Nagel, M. A., et al. 2011. Varicella zoster virus ischemic optic neuropathy and subclinical temporal artery involvement. Arch Neurol, 68, 517–20.10.1001/archneurol.2011.64CrossRefGoogle ScholarPubMed
Siddiqi, S. A., Nishat, S., Kanwar, D., et al. 2012. Cerebral venous sinus thrombosis: Association with primary varicella zoster virus infection. J Stroke Cerebrovasc Dis, 21, 917–4.10.1016/j.jstrokecerebrovasdis.2012.04.013CrossRefGoogle ScholarPubMed
Sreenivasan, N., Basit, S., Wohlfahrt, J., et al. 2013. The short- and long-term risk of stroke after herpes zoster: A nationwide population-based cohort study. PLoS One, 8, e69156.10.1371/journal.pone.0069156CrossRefGoogle Scholar
Stenmark, K.R., Frid, M.G., Yeager, M., et al. 2012. Targeting the adventitial microenvironment in pulmonary hypertension: A potential approach to therapy that considers epigenetic change. Pulm Circ, 2, 3–14.10.4103/2045-8932.94817CrossRefGoogle ScholarPubMed
Stevens, D. A., Ferrington, R. A., Jordan, G. W., and Merigan, T. C. 1975. Cellular events in zoster vesicles: Relation to clinical course and immune parameters. J Infect Dis, 131, 509–15.10.1093/infdis/131.5.509CrossRefGoogle ScholarPubMed
Sundström, K., Weibull, C. E., Soderberg-Lofdal, K., et al. 2015. Incidence of herpes zoster and associated events including stroke: A population-based cohort study. BMC Infect Dis, 15, 488.10.1186/s12879-015-1170-yCrossRefGoogle ScholarPubMed
Weber, D. S., Taniyama, Y., Rocic, P., et al. 2004. Phosphoinositide-dependent kinase 1 and p21-activated protein kinase mediate reactive oxygen species-dependent regulation of platelet-derived growth factor-induced smooth muscle cell migration. Circ Res, 94, 1219–26.10.1161/01.RES.0000126848.54740.4ACrossRefGoogle ScholarPubMed
Yawn, B. P., Wollan, P. C., Nagel, M. A., and Gilden, D. 2016. Risk of stroke and myocardial infarction after herpes zoster in older adults in a US community population. Mayo Clin Proc, 91, 33–44.10.1016/j.mayocp.2015.09.015CrossRefGoogle Scholar

Accessibility standard: Unknown

Why this information is here

This section outlines the accessibility features of this content - including support for screen readers, full keyboard navigation and high-contrast display options. This may not be relevant for you.

Accessibility Information

Accessibility compliance for the PDF of this book is currently unknown and may be updated in the future.

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×